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ACL tears are known to have a high rate of incidence amongst athletes. Due to its low 
vascularization and thus low healing ability, ACL tears eventually lead to degenerative 
joint diseases. The current gold standard for ACL tears is ACL reconstruction surgery 
with hamstring autografts. However, the primary focus is on mechanical fixation instead 
of the histological osteointegration of the graft within the bone tunnel; leading to inferior 
integration and graft pull-out and the need for a subsequent revision ACL surgery.  
 
The aim of this thesis is therefore to design and develop a 3D printed device as a graft 
sleeve in the promotion of osteointegration at the bone – graft interface within the bone 
tunnel for ACL reconstruction surgery applications. Using Solidworks, various designs 
were explored, tested and evaluated for its efficacy as a graft sleeve device. Concurrently, 
silk and silk-based materials were explored for their potential in being 3D printable 
bioinks for translation of the design from current non-biocompatible 3D printing 
materials to a biocompatible silk – based material. Studies for this thesis were separated 
into 2 phases, the design phase and the material phase: 
 
In the design phase, various tubular designs with locking or latching mechanisms and 
features like teethed protrusions along the inner walls of the sleeve were explored. 
Results showed that a full hollow tube structure with regular teethed protrusions along 
the inner wall of design had the best grip strength on the tendon graft enclosed within and 
also allowed for the successful pull-through of the graft – sleeve construct through the 





The form of the device (i.e. shape and structure) is closely dependent on its intended 
function.  Hence, whether the design of the device is translatable for a clinical ACL 
reconstruction surgery application is dependent on the biocompatibility, cell supporting 
ability, mechanical and structural properties of the material. In the material phase, pure 
silk solutions were first explored for their compatibility as a bioink material. However, 
results showed extruded pure silk solutions   had long gelation times and weak 
mechanical properties and were thus not compatible as bioinks. Following that, various 
silk-polymer composites were explored for their compatibility and silk/SDS/Pluronic 
composite showed the most promise as a future biocompatible bioink compatible with 
current 3D printing technologies.  
 
With the current work, it can be concluded that the final graft sleeve design is a 
reproducible alternative for current tissue augmentation devices and that the 
silk/SDS/Pluronic composite material may be a prospective biocompatible bio ink for the 
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1.1. Anterior Cruciate Ligament 
The anterior cruciate ligament (ACL) is one of the four major ligaments in the human 
knee joint that coordinates function and promotes stability [1]. Consisting of a band of 
dense connective tissues, the ACL is made up of two major fiber bundles - the 
anteromedial and posterolateral bundles. The ACL originates at the medial side of the 
lateral femoral condyle and passes obliquely through the intercondylar fossa before 
insertion at the medial tibial eminence [2, 3]. Being a key structure in the human knee 
joint, the ACL restrains anterior tibial translation with regards to the femur and resists 
abnormal rotational loads of the tibia. This helps in ensuring the stability of the knee joint 
and reduces the likelihood of ACL rupture [4].  
 
ACL injuries are one of the most common injuries of the knee and typically occur 
amongst athletes during high impact or high-pivoting sport activities when there is a 
sudden deceleration, twisting, cutting or jumping action [1, 5]. Over 200 000 patients are 
diagnosed with ACL tears annually with an incidence rate of 1 in 3000 [6, 7]. Due to the 
lack of sufficient vascularization resulting in the poor healing ability of the ACL, the 
instability in the knee persists and eventually results in degenerative joint diseases [1, 8]. 
Therefore, surgical intervention in the form of reconstruction with biological tissue grafts 
is required [2, 6].  
1.2. Clinical Treatment of ACL Injury  
In the past, there were many different methods of treating ACL tears; from non-operative 
techniques to surgical procedures. In the 1970s, primary repair of the torn ACL in the 
form of suturing was used but was later abandoned because of poor clinical results. In the 




grafts had complications such as increased wear debris and inferior clinical data. The 
current gold standard of surgical reconstruction of ACL is using local autografts or 
allografts because of their potential of undergoing remodelling and hence integration into 
the native joint [9-11]. 
 
During ACL reconstruction surgery, bone tunnels that pass through the original 
attachments of the native ACL are drilled through the tibia and femur. After suturing the 
harvested grafts into double bundle, the final graft is then passed through the two bone 
tunnels and then fixed using commercial fixation devices like interference screws. This 
fixation point is the weakest point of the graft and will remain the weakest point until 
healing in the bone tunnel occurs [8].  
1.2.1.  Autografts and Allografts 
The two most common autografts used clinically are the bone-patella tendon-bone (BPTP) 
and the hamstring tendon grafts. Traditionally, the BPTP autograft was preferred 
especially for young and active patients and was harvested generally from the middle one 
third of the patellar tendon with a portion of bone at each end. Thereafter, interference 
screws were used for fixation of the bone plugs in place [8].   
 
Compared with the hamstring tendon grafts, BPTP autografts were found to have better 
tissue-to-bone fixation strength and mechanical properties, improved bone-to-bone 
integration at the insertion sites and thus, faster healing with the native tissues. However, 
it has been found that the morbidity rates of knee ligaments using BPTB autografts were 
much higher and there were other implications such as weakness in the quadriceps, pain 
or fracture of the patella and the inability to kneel [1, 12-15]. Comparatively, hamstring 




decreased pain in the knee during kneeling and a thicker tendinous graft within the bone 
tunnel [9, 13-15].  
 
Alternatively, allografts have many advantages such as the elimination of donor site 
morbidity, smaller incision sizes and no limitations to its size. Nonetheless, allografts 
have their complications like limited supply due to a finite pool of donors, delayed 
biological incorporation and risk of transmission of blood-borne diseases. Possible host 
immune response, decreased mechanical strength due to sterilization processes required 
have also led to higher failure rates of ACL reconstructions using allografts [6, 7, 10, 13-
15].  
1.2.2. Synthetic Ligaments  
Synthetic grafts date back to the early 1970s as substitutes for ACL replacement grafts 
due to the shortcomings of autografts and allografts. They can be classified as grafts,  
stents or augmentation devices and prosthesis [16, 17].   
 
Currently, Food and Drug Administration (FDA) approved synthetic grafts in the market 
include grafts made of materials like polypropylene, polyethylene terephthalate and 
polytetrafluoroethylene (PTFE) [18]. However, though these grafts had satisfactory initial 
strength and provided initial stability to the knee, clinical success was limited because of 
foreign body response to the wear debris of the implant and the lack of integration with 
native tissues which resulted in mechanical fatigue and subsequent graft rupture or failure 
[6, 19]. 
 
The stent approach focused on the role of augmentation; where a mechanically inferior 




as the Kennedy ligament augmentation device. This method aimed to protect the 
autologous graft during early stage vascularisation when the artificial material performed 
its role as a load carrier so that there was gradual load transfer to the healing tissues [17, 
19, 20]. Unfortunately, such grafts may have an unintended stress-shielding effect on the 
autogenous tissue and prevent adequate mechanical strength development [17]. 
 
Lastly, prosthetic implants had been proven to have very limited success. These were 
usually in the form of scaffolds which induced fibrous tissue ingrowth and the formation 
of a neo-ligament at the intra-articular region which led to the subsequent increase in the 
ultimate strength of the synthetic ligament. Nonetheless, these prosthetics did not last 
because of their inability in replicating the native mechanical properties. Very often, 
repeated elongation caused permanent deformation and they were also associated with 
complications such as chronic effusions and synovitis caused by wear debris [16, 18].  
1.2.3. Tissue Engineered Constructs  
Tissue engineered constructs thus are developed to address the problem of long term 
efficacy of synthetic grafts. These constructs are capable of restoring normal joint 
kinematics to the native knee due to their improvement in mechanical properties over 
time [17]. In general, these scaffolds are designed to be implantable and at the same time, 
encourage the ingrowth of tissue and formation of neoligament. They may be seeded with 
cells from an autograft or allograft or surface modified for enhanced biocompatibility[7].  
(a) Biological Materials  
i. Collagen Scaffolds 
90% of the native ACL is made up of type I collagen. As such, extensive research had 
been done on the use of collagen-based scaffolds [6]. Initial studies with scaffolds made 




in vivo. However, collagen degrades rapidly and loses its mechanical properties over time. 
Hence, various techniques such as using collagen-glycosaminoglycan or collagen-elastin 
composites, cross-linked collagen or a twisted collagen braid were used for improved 
mechanical strength of the scaffold [6, 10, 15, 20]. Unfortunately, the improved 
mechanical strength still did not match that of native ACL and other concerns with 
leaching of crosslinking agents and immunogenicity with the use of collagen harvested 
from animals had pushed for the use of other materials with more favourable properties 
[6, 10, 21].  
ii. Silk Scaffolds 
Silk, an inexpensive and biocompatible material, is an improvement to collagen. With its 
outstanding and tailorable mechanical properties, silk fibres when braided into a rope-like 
geometry, has mechanical properties matching those of native functional ACL [22]. At 
the same time, it has a slow degradation rate in vitro and in vivo, undergoes complete 
degradation in 2 years in vitro [6, 20] and is able to maintain long term mechanical 
tensile integrity [15]. Compared with collagen scaffolds, the slow degradation rate of silk 
scaffolds is very critical in ensuring primary stability to the knee during the time for 
ingrowing cells to generate neoligamentous tissue [10]. When seeded with human bone 
marrow mesenchymal stem cells (BMSCs), silk scaffolds were found to support the 
regeneration of ligament 24 weeks after implantation in a porcine animal model [23].  
iii. Other Biological Materials  
Other biological materials used in ACL tissue engineering include hyaluronic acid [24], 
chitosan [25-27] and alginate [28-31]. Though these materials are highly biocompatible 
with the human body, the general disadvantage is that they lack mechanical strength [24-




(b) Synthetic Polymer Scaffolds 
Synthetic biodegradable scaffolds are versatile alternatives to scaffolds made from 
biological materials like silk and collagen. With different fabrication techniques and the 
wide selection of materials, scaffolds with the exact adaptation of native ACL’s 
mechanical properties and tissue response as well as degradation rate can be fabricated 
[10]. Biodegradable materials like polylactic acid (PLA), polyglycolic acid (PGA) and 
poly(lactide-coglycolide) (PLGA) were found to be unsuitable materials as ACL grafts as 
they are biologically inert and their degradation rates and hence loss in mechanical 
properties are too rapid for the remodelling rate of native tissues [21]. In addition, lactic 
acid and wear debris which are the byproducts of hydrolytic degradation of biodegradable 
materials, caused pH changes at the degradation site and bone resorption [32]. To 
improve the degradation rate, PGA scaffolds coated with polycaprolactone (PCL) to 
improve the degradation rate were demonstrated to have improved fibroblast attachment 
and proliferation [6, 10, 33]. Braided polydioxanone (PDS) scaffolds were considered but 
were found to have an early loss of their mechanical properties in in vivo animal studies. 
Poly L-lactic acid (PLLA) scaffolds manufactured in braid-twist manner had the best 
viscoelastic properties and cellular proliferation [6, 10].  
1.3. Unmet Clinical Need 
Despite the platitude of natural and synthetic grafts and scaffolds that can be used for 
ACL reconstruction, graft failure due to lack of healing at the bone-graft interface is still 
common [8]. The attachment site of the graft is very often the weak link post-surgery and 
is the reason for the delay in early return to function [34]. Hence, the integration between 
tendon graft and host bone is critical in ensuring a shorter healing time, improved fixation 




revision surgery [8, 35]. However, current techniques focus primarily on mechanical 
fixation alone and not on the histological tendon osteointegration.  
1.4. Aim 
Therefore, the aim of this thesis is to design and develop a 3D printed device that will 
have its future application in ACL reconstruction surgery; as a graft sleeve which helps in 
the promotion of osteointegration at the bone-tendon-graft interface within the bone 
tunnel. This device will act as a scaffold for support and mediation of bone growth at the 
interface and also potentially as a carrier for the osteoconductive factor, 
nanohydroxyapatite. 
1.5. Objectives and Scope  
This thesis has two main focus for the development of a successful ACL graft sleeve; 
design and material of the graft sleeve.  Chapter 1 provided a brief introduction of the 
anterior cruciate ligament in the human knee joint, the current gold standard of ACL 
regeneration and the current clinical problem of such a treatment method. Chapter 2 will 
provide the literature review for the current state of the art in improved osteointegration 
within the bone tunnel in ACL reconstruction, the different methods of scaffold 
fabrication with specific focus on 3D printing, its current technology and the bioinks 
currently available.  
 
The aim of the focus on design is to explore and develop the different scaffold designs for 
the purpose of enveloping the ACL graft like a sleeve and will be addressed in Chapter 3. 
In this chapter, the device design development will be addressed with the introduction of 
various scaffold designs developed using CAD drawings on Solidworks and printed with 
a commercial 3D printer. Thereafter, bench testing and Instron testing of the printed 




Chapter 4 addresses the aim of the material of the device; which is to explore the 
possibility of developing silk as a 3D printable “ink” for its subsequent use as a 
biocompatible material for fabrication of the ACL graft sleeve. This chapter will address 
silk as a 3D printable “ink” and explore other silk-polymer composites that could be the 
next novel material for use as a biocompatible 3D printable “ink”.  
 
A comparative discussion and conclusion will then be made in Chapter 5 where the 
potential bioink materials will be compared and the best material to be recommended for 
future works. Lastly, Chapter 6 will conclude the key results in this thesis and provide 




2 Literature review  
2.1. Background of the Enthesis  
In the human body, soft tissues like tendons and ligaments insert into hard tissues like 
bone, forming the enthesis which is very critical for musculoskeletal motion [36]. This 
functional integration zone has a very complex structure with graded mechanical 
properties to facilitate transmission and dissipation of physiological loads and stress 
concentrations; therefore ensuring smooth joint motion [37, 38]. The enthesis takes two 
forms, fibrous or fibrocartilaginous. Fibrous enthesis or indirect insertions have the 
characteristics of tendon incorporation to the periosteum during development while direct 
insertions or fibrocartilaginous enthesis have direct incorporation to the epiphysis or 
apophysis of a bone via a complex transitional tissue [39, 40].  
2.1.1. Structure of the Enthesis  
In the knee joint, studies have shown that there are four continuous transitional zones in 
the fibrocartilaginous enthesis; namely the ligament, the fibrocartilage, mineralized 
fibrocartilage and bone. These four zones have their characteristic spatial arrangement of 
cell types and composition of matrix; representing a gradual transition in composition, 
biochemical and structural elements.  The ligament is made up of interspersed fibroblasts 
within a matrix of collagen I and III fibers in parallel [36, 39, 41]. The fibrocartilage 
interface in zone 2 is unmineralized, has more random collagen bundles of collagen types 
II and III and chondrocyte-like cells arranged in rows or pairs in lacunae of extracellular 
matrix [37, 39, 41-43]. The deeper region of the fibrocartilage layer becomes calcified to 
form the mineralized fibrocartilage layer (Zone 3) and is made up predominantly of 
collagen type II and type X [36, 41, 43]. Zones 2 and 3 are separated from bone by the 
tidemark, a perpendicularly transversing line separating the two regions[38]. Lastly, Zone 




embedded within a highly calcified matrix made up predominantly of type I collagen [39, 
42].  
2.1.2. Development of the Enthesis  
In early human development, the ligament is attached to the hyaline cartilage which 
forms the anlagen for future bone [44, 45]. Type I, II and X collagen is localized at these 
ligament-to-bone insertion sites. The enthesis mineralization process acts similarly to that 
of chondrocyte hypertrophy at the growth plates. The type II collagen-expressing 
chondrocytes present in hyaline cartilage undergoes the cellular process of endochondral 
ossification. Very simply, bone microvessels penetrate into the cartilage and results in 
gradual bone tissue development along the blood vessels. This bone tissue expansion via 
ingrowth of blood vessel stops when no hyaline cartilage remains. Eventually, the 
undersurface of cartilage is eroded and replaced with bony trabeculae [46-48]. During 
this remodeling process, the collagen fibers and mineral continues to develop via 
fibroblast metaplasia and eventually, a well-organised and mature transitional tissue is 
formed [45]. On the other hand, the ligament cells at the ligament side undergo 
metaplasia into cartilage cells, thereby producing a layer of fibrocartilage [46-48].  
2.1.3. Importance of Enthesis for ACL reconstruction  
Enthesis development is very crucial for ACL reconstruction surgeries because the most 
common reason for graft failure is the lack of healing between the tendon graft and bone 
within the bone tunnel [8]. After implantation of the tendon graft, a layer of fibrovascular 
scar tissue forms between the graft and bone tunnel interface [8, 49] with no collagen 
continuity between the graft and bone. Then, new bone formation occurs along the bone 
tunnel [50].  Subsequent bone growth into the interface tissue with the resulting 
integration of the outer portion of the graft enhances the attachment strength of the graft 




found in fibrous enthesis, connects the graft to the surrounding bone.  Eventually, an 
interfacial tissue like a fibrous enthesis is formed, with continuity of collagen fibres 
between the graft and surrounding bone throughout the length of the bone tunnel [50, 51]. 
The graft can now be described as osteointegrated with native bone since the formation of 
such a fibrous enthesis prohibits any relative movement between the graft and the bone it 
has direct contact with [52]. However, this healing process is extremely slow because the 
fibrocartilage zone formed is avascular in nature and is further aggravated by the loss of 
bone at the site of injury when a bone tunnel is artificially created [40, 53]. In addition, 
the different healing rates of the tendon graft and native bone could be a potential reason 
for the lack of tissue integration. Tendons have low vascularity and cellularity and 
typically require a year of healing before return to its normal function whereas bone 
healing only takes 12 weeks [45]. Moreover, the native structure and composition of the 
enthesis is also not reformed during healing and this result in an interface that is 
mechanically and structurally inferior [38, 40, 45, 51, 53]. This often causes stress 




2.2. Current state of the art for ACL enthesis 
development 
The mechanical strength of the bone-graft attachment has been shown to correlate with 
the degree of osseous ingrowth and mineralization of the healing tissue [54, 55]. Till date, 
there is no optimal technique or method for improving osteointegration at this interface. 
Currently, there are various approaches for enhancing bone formation and  bone loss 
reduction in order to promote interfacial osteointegration [49]. These methods can be 
classified into six approaches; they are growth factors, biomaterial, chemical and 
biological agents, cell therapy, biophysical modalities and lastly gene transfer and 
therapy [45, 53].  
2.2.1. Molecular Approach  
(a) Growth Factors 
During tendon and bone healing, a large number of growth factors and cytokines are 
secreted [45] which helps in the regulation of collagen production. Specifically, insulin-
like growth factors I and II (IGF-1 and II), transforming growth factorβ (TGFβ), vascular 
endothelial growth factor (VEGF), platelet-derived growth factor (PDGF) and basic 
fibroblast growth factor (bFGF) are found to be upregulated and synergistically direct the 
healing process [50]. Other growth factors such as epithelial growth factor (EGF) 
combined with TGFβ, granulocyte colony-stimulating factor (G-CSF) and bone 
morphogenetic proteins (BMP) have also been employed at the insertion site [45, 53, 56]. 
BMP, members of the TNFβ superfamily, is the most potent osteoinductive growth factor 
with BMP-2 having the best positive results on bone formation and remodelling at the 
interface [50, 57]. Increasingly, platelet-rich plasma (PRP), an autologous derivative of 
blood high in platelets concentration, has been proposed as a novel and non-invasive 




being rich in growth factors and cytokines in a physiological combination, it provides an 
ideal local tissue healing and regeneration environment for improved osteointegration at 
the interface [50, 58].  
 
In general, with the introduction of these growth factors, an upregulation of osteogenic 
factors, increased cell proliferation, extracellular matrix (ECM) synthesis and deposition 
and increased collagen production has led to the enhanced osteointegration at the 
interface [6, 7, 10, 38, 45, 50, 53, 56, 58]. Nonetheless, concerns such as their short life 
span and the delivery and maintenance at the treatment site have limited the efficacy of 
these growth factors [6, 7, 10, 58].  
(b) Chemical and Biological Agents  
After ACL injury and reconstruction, the intra-articular environment is critical in the 
healing of the ACL. Matrix Metalloproteinases (MMPs) and Tissue Inhibitor of 
Metalloproteinase (TIMPs) are important enzymes in the process of tissue remodelling. 
Post injury, the levels of MMPs and TIMPs are observed to increase in the synovial fluid 
[59, 60]. Moreover, the balance of the levels of the two may affect the susceptibility to 
cartilage destruction [59]. α2-macroglobulin, a MMP inhibitor, was observed to enhance 
bone healing and increase collagen levels when applied at the bone tendon insertion site 
in animal models [45].  
 
The depletion of macrophages post-injury also plays a role in inflammation and tissue 
fibrosis, therefore affecting ligament healing. Liposome-encapsulated clodronate, an 
inhibitor of macrophages, when injected into mice models, demonstrated improved 




During the healing process, neovascularization and angiogenesis occurs. Hence, with 
hyperbaric oxygen treatment, neovascularization at the interface, collagen organization 
and tendon osteointegration was also similarly observed [53].   
2.2.2. Cellular Approach  
Stem cells are often used in tissue regeneration because of their potential for self-
renewing and multi-differentiation with the application of endogenous and exogenous 
factors [51]. Particularly, the use of mesenchymal stem cells (MSCs) in cellular therapies 
for musculoskeletal diseases has emerged as the current gold standard. MSCs are easy to 
expand and because of their multipotency and their ability to secrete bioactive growth 
factors and cytokines, they can provide a regenerative microenvironment and have the 
potential of restoring the native tissue structure [38, 60]. MSCs applied either via 
intravascular injections to graft surfaces or seeded in scaffolds were found to upregulate 
type II collagen production [62] and improve osteointegration of the graft to bone [59]. 
Synovial MSCs, which has a higher proliferation and differentiation potential when 
compared with BMSCs, showed accelerated fibrous structure formation and enhanced 
collagen fibres formation at the interface [51]. Bone marrow aspirates or periosteal 
progenitor cells introduced into bone tunnels with the tendon graft or wrapped as a piece 
of cell sheet around the tendon graft showed the extensive formation of new bone and 
fibrocartilage at the interface with excellent integration in between [8, 60, 63].  
2.2.3. Gene Therapy Approach 
Gene therapy in ligaments typically uses nonviral gene delivery vectors or viruses-
derived vectors where the viruses have natural entry pathways in the cell. Such a method 
allows the mediation of specific gene expressions to alter the synthesis of tissue 
endogenous proteins [58]. The primary advantage of this approach is that delivery of the 




factors. As such, by infecting tendon grafts with an adenovirus-BMP-2 gene, the 
integration of the tendon graft to the bone tunnel is shown to be improved [53]. BMSCs 
genetically modified with growth factors such as bFGF and BMP2 and transplanted to 
injury sites in rabbit models have revealed that healing is augmented. There were 
cartilage-like cells formed at the bone-graft interface, smaller bone tunnel area and 
improved ultimate load and stiffness [64]. Using an adenoviral vector-laden collagen 
hydrogel, growth factors like TGF-β1 and genes like IGF-1 cDNA can be transferred in 
situ to the injury site. Increased cellularisation and deposition of collagen I and III 
demonstrated enhanced osteointegration of the interface [65, 66]. Nonetheless, gene 
therapy has its disadvantages such as the high risk of mutagenesis, malignancy and 
toxicity. The loss or decrease in the expression of the transferred gene after a short period 
of time is also equally challenging [40, 53, 58, 64].  
2.2.4. Tissue Engineering Approach 
(a) Biophysical Modalities 
Low-intensity pulsed ultrasound has been demonstrated to be clinically beneficial for 
accelerating bone fracture healing and cartilage defects [45, 53, 67]. Not only is 
osteoblast activity and vascularization upregulated, tendon-to-bone healing is accelerated 
and the resulting interface morphology is similar to that of the native enthesis. The 
interface is also mechanically superior with an improved peak load to failure and stiffness 
when compared with controls in a sheep model [40, 68]. However, this approach is a time 
intensive procedure [40].  
 
Extracorporeal shockwave treatment is thought to affect the healing of bone through 
exerting direct pressure or causing cavitation. Less time is required as compared with 




pressure shockwaves alter the interface’s surround biochemical environment. This helps 
in the upregulation of growth factors, the creation of an environment with ingrowth of 
neovascularization and angiogenesis and increased formation of bone and collagen [69-
71]. Till date, the optimal parameters of use of this technique are still unclear [40].  
 
The use of mechanical loading for the regeneration of a functional bone-tendon interface 
has only been recently explored. It is postulated that during the process of endochondral 
ossification, mechanical loading is necessary for the continued maturation of mineralized 
bone [60, 72]. Physiological loading in the form of multidimensional mechanical strains  
when applied showed enhanced MSCs proliferation, upregulation of types I and II 
collagen and promoted ligament fibroblast induction of the cells within scaffolds [73, 74]. 
Other studies with delayed application of cyclic loading showed improved mechanical 
properties and biological parameters for enhancement of bone-tendon healing [40]. 
However, studies with short and low levels of controlled loading showed a decrease in 
the number of trabecular at the interface though tendon-bone healing was not affected 
[75]. This indicates that till date, there is no ideal mechanical stimulation regime in terms 
of type, magnitude, and duration of mechanical stimuli for enhancement of bone-graft 
integration [73, 74, 76, 77].  
(b) Biomaterial 
Having a similar composition to native bone, calcium and magnesium phosphate 
biocements or adhesives are used to enhance osteointegration at the interface [53]. These 
bone cements together with brushite calcium phosphate cement (dicalcium phosphate 
dihydrate) provides a biocompatible and osteoconductive environment for enhanced cell 
proliferation and recruitment of growth factors [40]. Tricalcium phosphate and 




coatings to tissue engineered scaffolds, were observed to induce bone development and 
osteointegration at the interface. The precipitation of calcium phosphates onto the tendon 
graft forming a “hybridized” graft has also been shown to enhance tendon-bone healing 
more quickly and the mechanical strength of the interfacial tissue was also much stronger 
[8, 40, 45, 49, 53]. Demineralized bone matrix is another alternative that has been shown 
to induce the growth of more fibrocartilaginous tissue and mineralized fibrocartilage and 
possibly an enthesis interface which is physiologically similar. However, the mechanical 
strength of such an interface has yet to be determined [8, 45].   
(c) Synergistic Approach 
As discussed above, the regeneration of the native tendon-bone interface is extremely 
challenging. It is necessary to reconstruct the complex tissue gradient of native interface 
ex vivo and subsequently maintain this gradient through the application of growth factors 
at the insertion site in vivo. Therefore, a synergistic approach of using cells and scaffold 
is the proposed approach to successfully promote osteointegration at this interface [38].  
2.3. Current state of the art – Scaffold Fabrication for 
Tissue Engineering Applications 
In tissue engineering, a well-designed three-dimensional scaffold with the appropriate 
geometry and physical structure is critical for enhancing cell penetration and guiding 
tissue formation in vitro and in vivo.  Conventional scaffold fabrication techniques 
include solvent casting and particulate leaching, phase separation, gas foaming and freeze 
drying [80-83]. However, these techniques are limited in the control of pore sizes 
geometry, interconnectivity and spatial distribution [84, 85]. Moreover, the scaffolds 
produced with conventional methods have weak physical and mechanical properties and 




rapid prototyping [85] and biofabrication [86] have evolved so as to provide chemical, 
mechanical, structural and biological supports [84].  
2.3.1. Conventional Techniques 
(a) Solvent Casting & Particulate Leaching 
There are two methods of solvent casting: the first method is to dip the prepared mould 
into a polymeric solution and allow the mould to dry while the second method involves 
pouring of the polymeric solution onto the mould and the subsequent slow evaporation of 
the solvent. Both methods create a polymeric membrane that adheres to the mould after 
the evaporation of the solvent [84]. For the creation of porous scaffolds, the solvent 
casting method is typically used together with the particulate leaching method. Briefly, 
the polymer is dissolved in an organic solvent before the addition of porogens (i.e. salts 
or sugars of desired sizes). The mixture is then cast onto a mould and the solvent is 
allowed to evaporate. Following that, the scaffold is immersed in water for the leaching 
out of the salt crystals, creating porous scaffolds [82]. While these methods are simple in 
obtaining desired pore size percentages and crystallinity, the shapes and interconnectivity 
of the pores created, the internal architecture and topology are uncontrollable and the 
maximum membrane thickness that was obtained was only 3mm [82, 84, 87].   
(b) Phase Separation 
This method involves the separation of the polymeric solution into the polymer-rich and 
polymer-poor phase via a change in temperature or with a non-solvent. Phase separation 
via the use of a non-solvent is not optimal for tissue engineering applications as a 
heterogeneous pore structure is created. The polymer solution is first quenched at low 
temperatures and becomes thermodynamically unstable. Hence, it undergoes a phase 




The polymer-rich phase solidifies and forms a matrix whilst the polymer-poor phase 
forms pores from the removal of solvent [81, 82, 84].  
(c) Gas Foaming 
During this process, gas-foaming agents such as carbon dioxide and nitrogen, water or 
fluoroform are used. The polymers are pressurized at high pressures with the gas-foaming 
agents till saturation and this result in the nucleation and growth of gas bubbles in the 
polymers which creates pores in the polymer volume. The extent of porosity is dependent 
upon the porogens used. One major advantage of this technique is that organic solvents 
do not need to be used. However, the final scaffold fabricated yields a structure with 
largely unconnected pores and an external surface that is non-porous [81, 82, 84]. 
(d) Freeze Drying 
Freeze drying process is typically carried out in 2 phases. In the initial freezing phase, the 
polymer is cooled down till ice crystals are formed in the solvent, forcing the aggregation 
of polymer molecules into the interstitial spaces. Subsequently, removal of the solvent is 
done via the application of a partial vacuum pressure and a dry interconnected random 
porous scaffold is formed when all solvent is sublimated and unfrozen water is removed 
by desorption [81, 82].  
2.3.2. Advanced Techniques 
(a) Electrospinning 
This widely used technique uses electrical charges in the fabrication of nano-scale or 
micro-scale fibers with small pore sizes and high surface area to volume ratios. Firstly, a 
high voltage source is applied to a polymer solution or melt filled capillary tube. By 
surface tension, the solution or melt is held at the tip of the capillary. Upon application of 
an electric field, a mutual charge repulsion opposite to that of the surface tension is 




repulsion overcomes the surface tension, forming a jet. Lastly, as the ejected jet travels to 
the collector where collection of fibres occurs, repulsion between the solution and melt 
occurs, causing solvent evaporation to form fibres [81, 82, 84]. The process is 
advantageous mainly due to its versatility and non-invasiveness, and coagulating agents 
or high temperatures are not required [84]. Moreover, scaffolds fabricated via 
electrospinning have been proven to promote cell adhesion, growth and proliferation and 
binding [88, 89]. Nonetheless, complex topography and structures and homogenous pore 
distribution through the scaffold is still non-achievable via electrospinning [81].   
(b) Rapid Prototyping 
Solid freeform fabrication is a fabrication technique which produces freeform solid 
objects from a computer model directly; without any human intervention or tooling [90] 
and rapid prototyping is one of the advanced forms of this technique[84].  Basically, 
rapid prototyping reads the information from computer-aided design (CAD) drawings, 
converts the information to an STL type file format and then into a series of cross-
sectional layers to be read by the printer. This bottom-up approach manufactures three-
dimensional scaffolds in a layer-by-layer fashion according to the drawing; with each 
layer glued or bonded to the previous layer [85, 91]. Based on the type of scaffold 
biomaterial that is required, the ideal type and technology of rapid prototyping is selected. 
Generally, for tissue engineering applications of biological material deposition and 
patterning, the main technologies used are inkjet, extrusion and light-assisted. Selection 
of the technology is based on the surface resolution and cell viability of the printed 




i. Inkjet Printing 
Inkjet printing is the most commonly used technique for both non-biological as well as 
biological applications. Ink cartridges loaded with biological materials are used and 
controlled volumes of protein or cell solutions are dispensed onto an electronically 
controlled elevator stage. Thermal or acoustic forces are used to eject liquid droplets onto 
a substrate which is a support or part of the final scaffold [87, 92, 93].  
 
In thermal inkjet printers, the printer head is electrically heated, producing pressure 
pulses and forcing the droplets from the nozzle. Inkjet printers are cheap, widely 
available and have high print speeds. Nonetheless, there are concerns with non-uniform 
droplet size, exposure of the biological materials to thermal and mechanical stresses and 
frequent nozzle clogging.   
 
Acoustic forces are generally produced by a piezoelectric crystal or by application of a 
voltage to a piezoelectric material. The pressure pulses generated ejects the droplets from 
the nozzle. Comparatively, this technique produces droplets of uniform sizes and 
controllable rate of ejection and avoids thermal or mechanical stresses on cells [87, 92].  
ii. Extrusion Printing 
This technique of printing focuses on the principle of extruding continuous material 
filaments through a fluid dispensing system. A pneumatic or mechanically driven 
pressure system is used to generate continuous beads of materials for the continuous 
deposition of filaments in the xy plane. As such, this technique provides better structural 
integrity to the scaffold [93, 94]. The stage or the extrusion head is then moved along the 
z-axis for deposition on the previous layer. One example of this technique is Fused 




used is heated at the extrusion nozzle head to the melting temperature of the polymer 
material. Upon extrusion, the intrinsic property of the polymer material causes the 
immediate hardening of the material to form layers [84]. In tissue engineering 
applications, very often the bioinks have shear thinning properties to allow for easy flow 
through the nozzle yet have high viscosities upon deposition. Materials that can flow at 
room temperature but undergoes cross-linking and gelation at physiologically suitable 
temperature or vice versa have also been used [92, 93]. Other bioink materials are 
crosslinked by light and chemical stimulus upon deposition. This technique is the most 
convenient for creating porous scaffolds and for tissue and organ fabrication [94]. 
However, the printing resolution and speed is inferior and cell viability after printing is 
low due to high shear stresses within the nozzle [92, 94].  
iii. Light Assisted Printing 
Light assisted printed involves the process of photo-polymerisation of the biomaterials 
and can be classified into two subgroups: digital light processing (DLP)-based printing 
and laser-based printing[87, 93].  
 
In DLP-based bioprinting, a digital micromirror device is used for UV light modification. 
An entire plane of optical pattern (i.e. the mask image) is then projected onto the 
photopolymer solution which significantly reduces printing time. At the same time, 
artificial interfaces such as between droplets in inkjet printing and lines in extrusion 
printing are avoided and the mechanical integrity of the printed scaffolds is enhanced; 
allowing for complex structures to be printed [87].  
 
On the other hand, laser based printing is based on the Laser-Induced Forward Transfer 




Briefly, the laser pulse is focused on the absorbing layer of either gold or platinum which 
creates a higher pressure bubble in the bioink layer. This induces shock waves, generated 
by the bubble formation, to transfer the bioink onto the collector substrate [92, 94, 95]. 
The technology of using lasers was first formulated in 1986 and is known as 
stereolithography. In this technique, a UV laser traces a cross section of the patterns on a 
curable photopolymer resin. The solidified layers are able to join together when the resin-
filled blade is refilled [84]. One special type of laser-based printing, two-photon 
polymerization uses a near-infrared femtosecond laser to trigger a nonlinear optical effect 
in the bioink. The bioink then undergoes polymerization and produces scaffolds of 
extremely high resolution[87].   
 
In general, laser based printing is an emerging technology with many advantages over 
inkjet and extrusion printing; there is no nozzle clogging because no nozzles are required, 
it has high precision for the formation of intricate microscale features. However, due to 
the use of lasers, cell viability in these bioinks is generally low and there are limitations 
to printability in the z-direction. In addition, fast gelating bioinks are a requirement, there 
may be possible contamination from the use of photoinitiators and fabrication time is 
generally longer [87, 92, 94, 95].  
iv. Direct Write Assembly 
This printing method is primarily used to achieve fine feature sizes. Through a microscale 
orifice, beads of materials are dispensed directly into an environment which initiates the 
curing of the material via temperature, light, humidity gradients or other chemical 




2.3.3. 3D Printing – Bio-inks    
As discussed in previous sections, 3D printing is increasingly being adopted for scaffold 
fabrication in tissue engineering as it allows for the reproducible and large-scale 
fabrication of complex and physiologically relevant geometries of extremely high 
precision that were previously impossible. There are many designs and technologies of 
3D printing and similarly, there are many materials that could be used for 3D printing. 
Very often, properties of these materials that enhance its printability have an opposite 
effect on its biocompatibility with the human body [96].  
(a) Properties of a bio-ink  
Ideally, printable biomaterials must have properties that allows for both printing efficacy 
and cytocompatibility [97]. This compromise of having cell viable bioinks to have 
passable yet suboptimal print fidelity is termed as the biofabrication window.  In the 
selection of the optimal materials as a bioink, the material, rheological, chemical and 
biological characteristics are very critical [98].  
i. Material Properties  
The hydration, degradation rate, mechanical stability and permeability of the bioink are 
important material properties that have to be considered. Besides influencing the eventual 
viscosity of the bioink, the hydration and permeability of the material also affects the 
oxygen and nutrient transport to cells within the printed scaffold, the mechanical strength 
and viscoelasticity of the final construct and its swelling properties [96-98]. However, 
there is a trade-off between porosity or hydration and mechanical strength; with increased 
pore sizes or water content, the mechanical strength of the final construct decreases [97]. 
The mechanical properties and degradation rate of the material also influence the cellular 
proliferation and differentiation within the scaffold, extracellular matrix production and 




ii. Rheological Properties  
The consistency, printability, extrusion rate, resolution and eventual shape retention of 
the bioink are highly dependent on its viscosity. Too high a viscosity will result in 
clogging or fracture at the dispensing tip whilst an inadequate viscosity imparts 
detrimental shear forces on the cells. Hence, materials that exhibit shear-thinning 
properties are best used in printing; there is reduced nozzle-clogging while the cells 
remain viable and uniformly encapsulated in the low viscosity biomaterial solution [96-
98]. The initial viscosity of the bioink also affects the subsequent cross-linking 
mechanisms for an eventual stable construct [91].   
iii. Chemical Properties  
The chemical properties of the material affects its gelation kinetics and in turn, its 
mechanical properties, biocompatibility, print resolution and structural integrity [96].  
Sufficient cross-linking within a single layer has to occur to achieve structural integrity 
and the challenge is in achieving it without application of cytotoxic processing [91]. The 
polymer backbone chain mobility and concentration affect the type of cross-linking 
mechanism (i.e. physical or chemical crosslinking) that can be used. In general, 
temperature- based crosslinking provides a fast yet unstable construct while chemical 
dependent crosslinking such as photonic, ionic, electrostatic and pH provides a slower but 
more permanent construct. The degree and mechanism (i.e. temperature and solvents 
used) of crosslinking can influence the printing resolution, mechanical properties and 
cytotoxicity of the construct [96, 97].  
iv. Biological Properties  
The biological interactivity of the bioink material is dependent on its eventual 
applications.  The tissue engineered printed constructs should allow for cellular 




Moreover, the degradation rate of the biomaterial also affects the remodelling and 
cytocompability of the scaffold [91].  
(b) Types of bio-ink  
There are three main categories of bioink: matrix, sacrificial and support. Depending on 
each category, the bioink properties required has its own specific characteristics [96].  
Matrix bioinks are usually media suspended cell slurries or cell-encapsulated synthetic or 
natural hydrogels. Hence, during the printing process, it is critical for the bioink to shield 
the cells from shear stresses. A quick, non-toxic gelation mechanism is also required to 
achieve optimal print resolution and shear thinning biomaterials are often used. Finally, 
the biomaterial should be degradable, biologically interactive and have hydration, 
porosity and mechanical properties similar to that of the native extracellular matrix [91, 
96]. Examples of such bioinks include collagen, fibrin, silk fibroin, gelatin and its 
functionalized variations, alginate and chitosan [96, 97, 99].  
 
Sacrificial bioinks offer temporary support or are a part of an intricate 3D printed 
geometry and are often used with matrix bioinks. High viscosity or shear thinning 
biomaterials are preferred for smooth extrusion and high print fidelity. In addition, it 
should be cytocompatible and easy to remove. Common sacrificial bioinks include 
gelatin, Pluronic [100], agarose [101] and carbohydrate glass [96].  
 
Support bioinks are a more permanent support as compared to sacrificial bioinks. These 
bioinks together with matrix bioinks enhances the mechanical properties and structure of 
the printed construct. Hence, these biomaterials should have high mechanical strength 




Examples of support biomaterials are polylactic acid, poly(l-lactic acid), poly(lactic-co-
glycolic acid) and polycaprolactone [96, 99, 102].  
(c) Silk-based bioinks  
There are many materials that are being explored as potential bioinks. These range from 
natural materials such as polysaccharides (i.e. agarose, alginate, chitosan, dextran, starch), 
proteins (collagen, fibrin, gelatin, silk fibroin) and glycosaminoglycans (i.e. chondroitin 
sulfate and hyaluronan) to synthetic polymers such as polyethers (i.e. poly(ethylene 
glycol), polyesters (i.e. poly(caprolactone), poly(glycolic acid), poly(lactic-co-glycolic 
acid)), other polymers such as poly(vinyl alcohol) and poloxamers like Pluronic F127 [91, 
96-99, 101, 103]. The following literature review shown in Table 1 will be focused on 
silk-based bioinks as silk is the only protein that matches the native mechanical 












Table 2- 1: Silk-based bioinks for Tissue Engineering Application 
 Bioink Crosslinking 
Mechanism 
Advantages Disadvantages References 
Pure Silk 
Silk fibroin Self-assembly 
Control over microscale 
structures and composition 
Risk of nozzle clogging [104-106] 
Silk fibroin Photonic 
Formation of high resolution 
microstructures 
Presence of photo-reactive 
groups 
[107] 
Silk fibroin Physical Simple 





Spider Silk Fibroin Physical 
No crosslinking additives or 
thickeners required 






Silk/HRP/H2O2 Enzymatic Low injection force required Slow gelation [110-113] 
Silk/Riboflavin Photonic 
Precise control over 
mechanical properties of gel 
Slow gelation and use of 
lasers required 
[114] 





Controlled pore size and 
porosity gradients 




Rapid gelation; good cell 
adherence  
Weak mechanical 







Decreased resolution and 
weak mechanical properties  
[118, 119] 
Silk/Alginate  Chemical,  
Enzymatic 
Fast gelation, Easy removal of 
alginate 
Lack of cell adherence  and 





polymer; no harsh crosslinking 
mechanisms required  






Excellent shape retention, 
Non-toxic printing and post 
printing curing  
Potential of phase 
separation of components 





3. Device Design Process  
As covered in Chapter 2, there has been extensive research ongoing in the field of 
enhancing osteointegration at the bone-ligament interface. Nonetheless, current 
techniques primarily focus on mechanical fixation of the graft and not on the regeneration 
of the native enthesis to enhance recovery. Hence, there is a critical need to address the 
histological osteointegration at the bone-ligament interface and it is hypothesized that a 
graft sleeve at the interface will help address this clinical problem.  
3.1. User Needs 
In the design of such a graft sleeve device, the identification of the requirements of the 
user is important. Ultimately, the product should be designed to have features that will 
fulfil the user needs and also address existing constraints and their importance. In 
addition, the user needs have to be ranked with the most general primary needs at the top. 
This ranking of the need importance is essential for subsequent trade-off analysis in the 
design process and will determine which features are more critical for the successful 
design of the device [124, 125]. Below is the table of user needs identified for the graft-
sleeve device and its importance.  
Table 3- 1: User Needs 
No User Needs Importance 
1 Biocompatible with the body 1 
2 No micro movements of graft within bone tunnel  2 
3 Enhances osseointegration between graft and bone 3 
4 Does not break apart during passage through bone tunnel 4 
5 Does not slip off the graft during passage through bone tunnel 4 
6 Allows cellular and fluid exchange between bone tunnel and graft  5 
7 Biodegradable over time 6 
8 Sterile for use 7 





3.2. Metric Table  
The user needs in Table 2.1 are then translated into measurable characteristics that can 
reflect the extent to which the product will satisfy the user needs. The underlying 
assumption is that this translation is possible and that each need is specified by only one 
metric. Fulfilling this one metric will then ensure that the user need is met. However, it is 
often difficult to represent one user need with only one metric. Hence, a few metrics may 
be used to describe a particular user need [125].  
Table 3- 2: Metrics 
No Metrics Units Importance  
1 Extent of irritation when implanted into the body Qualitative 1 
2 Thickness of wall of device mm 2 
3 Length of device mm 2 
4 Diameter of device mm 2 
5 Average time before increased cell proliferation is 
observed 
Days 3  
6 Average time before increased cell differentiation 
is observed 
Days 3 
7 Pull through strength N 3 
8 Radial extension of device before failure % 4 
9 Tensile strength of device before failure  N 4 
10 Porosity of device % 5 
11 Average diameter of pore sizes and its range µm 5 
12 Degradation rate of device Years 6 
13 Material safe for sterilization methods Yes/No 7 
14 Average time taken to load graft into device minutes 8 
3.3. Needs-metrics Matrix 
The needs-metric matrix is a common tool used in the representation of the relationship 
between the user needs and the specified metrics. This helps in ensuring that all user 
needs are met in the design process. Very simply, the user needs are represented in the 
rows of the matrix while the metrics are represented in the columns. A cross in the cell in 






Table 3- 3: Needs-Metric Matrix 
 
3.4. Benchmarking with current device  
Lastly, benchmarking was done with a similar device, the tissue interface augmentation 
device for ligament or tendon reconstruction [126] to determine the design specifications 
of the design to match up to a similar device that is currently available. This process 
allows for the assigning of target specifications (i.e. optimal values) to each metric for 
easy design verification and validation in the later stages of device design [125, 127].  





Units  Importance Optimal Values  Minimum 
Acceptable Value  
1 1 Qualitative 1 Moderate irritant  Moderate irritant 
2 2,3 mm 2 0.99 1 
3 2 mm 2 30 35 
4 2,3 mm 2 5 6 
5 3 Days 3 7 10 
6 3 Days 3 14 20 
7 3 N 3  0.952 ± 0.0010 0.8 




9 4 N 4 8.08 ± 2.22 7.5 
10 6 % 5 70 65 
11 6 µm 5 150 ± 20  200 ± 20  
12 7 Years 6 1 1.5 
13 8 Yes/No 7 Yes Yes 
14 9 minutes 8 30  35 
 
3.5. Design Rationale & Verification  
Based on the user needs, the biocompatibility of the material is critical. As covered in 
Chapter 2, although silk is an excellent material for ACL regeneration applications, there 
are currently no silk or silk-based biomaterials with properties suitable for printing with 
conventional 3D printers while having similar mechanical properties as silk braided 
fibres. Hence, a reverse approach was adopted; to develop an optimal and reproducible 
3D printable design with conventional 3D Rapid Prototyping materials before developing 
a silk-polymer composite with the suitable mechanical properties which match the 
properties of the Rapid Prototyping material for the optimal design.  
    
The below mentioned designs were printed with the Objet260 Connex3 3D printer from 
Stratasys, USA. A range of additive manufacturing Stratasys materials (Stratasys PolyJet 
Materials Data Sheet) were used to print the designs below: 
(a) Transparent material (VeroClear-RGD810) 
(b) Rubber-like black material (TangoGray FLX950) 
(c) Rubber-like black material with different ratios of Veroclear Material 
and TangoBlack material as per Table 3.5 
Table 3- 5: Rubber-like material with different ratios of transparent veroclear 
material  
Primary Material: TangoBlackPlus FLX 980   
Secondary Material: Veroclear RGD810 
Material FLX9040 FLX9050 FLX9060 FLX9070 FLX9085 FLX9095 
Ratio of Primary 
Material  
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Figure 3- 1. Solidworks Images of Design 1 with length 30mm, diameter 5mm, wall 
thickness 1mm and pore diameter 1.5mm. Design 1 works on the principle of a snap 
fit of 2 components to form a hollow cylinder (a). The locking component with 
teethed edge at the top and a slotting component at the bottom (a1) fit into the 
adjacent “docking” component with teethed slots and bottom slotting component 
(a2). 
 
Design 1 is based on the principle of a snap fit assembly method of attaching 2 different 
components to form the final cylindrical shape by pushing the 2 components’ 
interlocking features together (Figure 3- 1). The rationale is because snap fit assembly 
methods can be done very easily and quickly and do not have any loose parts unlike 
assembly methods using nails or screws. There are 2 opposite components in this design; 
the teeth on the top edge and the slotting component at the bottom edge of component B 





Initial benchtesting with printed designs of either pure Veroclear material or TangoGray 
material showed that both these 2 materials were not feasible for this design. Veroclear is 
too stiff for the snap fit assembly to work and resulted in breaking of the components 
while TangoBlack material is too soft and the components break when too much 
mechanical force is applied.  Moreover, as the scale of the resolution of the features (i.e. 
teeth and slots for the teeth to fit into) is in the millimetre range, the strength of the snap 
fit assembly is not that strong and the two opposite components are not able to interlock 
and hold together. Hence, this design was considered to be not very feasible.  






Figure 3- 2. Solidworks Images of Design 2 with breadth 30mm, diameter 5mm, wall 
thickness 1mm and pore diameter 1.75 mm. Design 2 works on the principle of a 
press fit assembly with the “buttons” diameter 2mm circled in red (a1) press fit into 
their corresponding adjacent slots (a).  
 
Design 2 is based on the principle of a press fit assembly method of pulling the edge with 
the “buttons” over to the edge with the slots and then pushing the buttons into the slots to 
fix the shape (Figure 3- 2). The rationale is because the press fit assembly method allows 
for a simple securing of the 2 edges to form a smaller diameter cylinder when the buttons 
are held in place in their slots via friction. The shrinkage of the overall diameter of the 





Similar to Design 1, initial benchtesting with printed designs of either pure Veroclear 
material or TangoGray material showed that both these 2 materials were not feasible for 
this design. Veroclear is too stiff for the compression from a bigger diameter cylinder to 
that of a smaller diameter and resulted in breaking of the material (see Figure 3- 3) while 
TangoGray material is too soft and the components break when too much mechanical 
force is applied.  Moreover, a major limitation is that with this design, there is an 
overlapping thickness at the region where the buttons sit into their respective slots. The 
increase in double the thickness will result in a decreased osteointegration at this region 
and therefore an overall non-uniform osteointegration effect when this device is used in 















Figure 3- 3. Points of failure of Designs 1 and 2. The first design printed with 
TangoGray material (a1) and Veroclear material (a2) breaks and cracks at the red 
circled areas when the slots are being pressed into their corresponding docking slots 
(a). Similarly, the second design printed with TangoGray material (b1) and 
Veroclear material (b2) fractures along the red line in a longitudinal manner.    
 
3.5.3. Design Iteration 3 
 
















Figure 3- 4. Other Designs based on the rationale of 2 interlocking halves. The top 
half of semi-circle with diameter 3mm and wall thickness 1mm with its protruding 
slots (a1) is to be pressed fit into the slots in the bottom half of the semi-circle design 
(a) through the press-fit mechanism. The second design uses jagged edges along the 
sides of the wall to hold the two halves of the cylinder of diameter 5mm and wall 
thickness 1mm together (b). The third design with teeth of height 0.4mm on the 
shorter part of one half of a circle of diameter 5mm and wall thickness 1mm  (c1) 
slotting into the empty slots of the longer half of the circle (c) in a sideways manner.   
 
The above 3 designs (Figure 3- 4) are based upon the idea of 2 interlocking halves of a 
cylinder being fitted to each other via various assembly methods to form a full hollow 
cylinder that resembles a sleeve. For Design A, the upper half of the hollow cylinder has 
protruding features that will act as the anchorage holding the upper half and bottom half 
together when the protruding features sit into the empty slots at the bottom half. For 
Design B, a similar anchorage and assembly method is adopted; in replacement of the 
protruding features, jagged edges opposite in direction are present along the sides of the 
wall to hold the two halves of the cylinder together. Lastly, in Design C, the pointed 
teeth-like features of the semi-circle fit into the empty slots of the half-circle with a 
longer arc length, thereby locking the 2 halves together.  
 
However, one major recurring limitation with such a design that aims to assemble two 
interlocking halves together is the strength of the interlocking mechanism. Due to the 




interlocking mechanism, the strength of the interlocking mechanism is not strong enough 
for the two halves to hold together. A typical observation is that the slots are too shallow 
because of the limited thickness of the designs of 0.5mm and this resulted in the easy 
slippage of the protruding features, jagged edges or teeth-like features out from their 
respective slots.  










Figure 3- 5. Solidworks images of designs that fold into itself. The first design works 
on the principle of a bigger diameter of 7mm folding into a smaller diameter circle 
of 4.5mm through the protruding slotted edges of thickness 0.25mm folding 
sideways seen from the front view (a) and the side view (a1) with total wall thickness 
of 1.25mm.  The second design follows the principle behind jigsaw puzzles where the 
interlocking features of breadth 4mm and 5mm apart at both of the longitudinal 
edges of length 30mm (see side view (b)) catch onto each other to form a full circle of 
diameter 6mm (b1).  
 
In iteration 4, the above 2 designs (Figure 3- 5) are based upon the idea of designs that 
will fold into itself and be held in place. In Design A, when the protrusions (circled in red) 




diameter of the hollow cylinder will compress towards each other. This forces the 
diameter of the lumen of the hollow cylinder to shrink and will exert a mechanical 
constrictive force on the graft hence holding it in place. On the other hand, Design B is 
based on the rationale behind how jigsaw puzzles are able to fit and hold onto each other. 
Design B is printed as a flat piece before bending the edges of this piece towards each 
other so that the interlocking features at the two corresponding edges can fit into each 
other.   
 
When conducting bench testing on both designs, a persistent limitation occurs similar as 
in iteration 3. Due to the micro-scale dimensions of the printed designs and the features 
responsible for the interlocking mechanism, the strength of the interlocking mechanism is 
not strong enough for the two halves to hold together. In Design A, the protrusions tend 
to slip out of their slots and the inner circle expands outwards while in Design B, the 
interlocking features do not hold onto each other and tend to unroll back to its original 
flat shape.  








Figure 3- 6. Solidworks Images of full hollow cylinder designs. Both designs are of 
the same inner diameter of 5mm and wall thickness 1mm with differing shapes of 
the cross-section (i.e. hexagaonal (a) and circular (b)) of the lumen of the hollow 




In the last iteration, the above 2 designs (Figure 3- 5) are full hollow cylinder designs 
that are of a smaller diameter than the graft size. Based on the elasticity of the material, it 
can be expanded circumferentially for the insertion of the tendon graft before it returns to 
its original diameter and hence, exerting a circumferential constriction force inwards onto 
the tendon graft. Previous 4 design iterations have showed that there is limited 
interlocking strength exerted by the interlocking features to hold two halves of a hollow 
cylinder together due to the micro-dimensions of the device. Hence, a full hollow 
cylinder design was considered. At the same time, the optimal 3D PolyJet Material to be 
used is FLX 9095; any increasing ratios of TangoBlack material results in the material 
being too soft to be manipulated and breaks very easily. The hexagonal design was 
chosen over that of the circular design because the sharp protrusions within the interior 
walls of the circular design tend to break off during removal of support material due to its 
small surface area.   
3.6. Design Validation  
There are a few parameters of the full hollow cylinder design that has to be considered.  
For each parameter, experiments with 3D printed designs using FLX9095 Rapid 
Prototyping material were conducted to determine their optimal values and statistical 
analysis involving multiple comparisons were evaluated using a one-way analysis of 
variance (ANOVA) test and post-hoc Tukey correction using OriginPro 9 (OriginLab). A 
p-value of less than 0.05 was taken as significant and all experimental data were 
expressed as means ± standard deviation.  
3.6.1. Internal Diameter of Hollow Cylinder 
There are two considerations for the internal diameter of the hollow cylinder; the 
elasticity of the material and the diameter of the tendon graft. In typical human ACL 




greater than 8mm were found to have decreased failure rates [128-130]. However, in a 
current preclinical study with a total of 30 porcine models, the tendon graft made from 2 
harvested porcine flexor digitorum profundus tendons sutured together along its length 
were found to have an average diameter of 6mm. With the same source of flexor 
digitorum profundus tendons being used for bench testing of the 3D printed designs, the 
internal diameter of the hollow cylinder were therefore determined to have a maximum of 
6mm in diameter. At the same time, uniaxial tensile testing of a 1mm thickness FLX9095 
material (see Table 3- 5), used for printing of the 3D device, with the Instron 3345 
machine (Instron, Norwood, MA, USA) has showed a 36.08 ± 7.81 % elongation at break. 
Hence, taking both limits into consideration, the internal diameter of the device is 4.4 – 
6mm.  
3.6.2. Thickness of Device  
The optimal thickness of the device should satisfy the requirements of being relatively 
thin so as not to interfere with the osteointegration function of the device yet relatively 
thick to allow for easy loading of graft onto the device without failure. Hence, the devices, 
with an internal diameter of 4.5mm, were printed with a series of different thickness (i.e. 
0.4mm, 0.5mm, 1mm, 1,2mm, 1,5mm, 1,8mm and 2mm). These thickness values were 
chosen to determine the upper and lower limits for this sleeve application. Bench test 
with the radial expansion of the internal diameter of the device with forceps and a vernier 
caliper showed that that a thickness of 0.4mm is not feasible as the device breaks even at 
the initial stage of removal of support material from the lumen of the design. From 
Figure 3- 7, the maximum percentage change in diameter of 36.89 ± 1.22% was 
observed for devices of thickness 1mm. This is significantly higher than devices with 
thickness of 0.5mm, 1.5mm, 1.8mm and 2mm (i.e. when the difference in thickness is 




the extensibility of the material and thus the ease of loading the tendon graft into the 
device. Hence, the thickness of the material was determined to be that of 1mm.    
 
Figure 3- 7. Percentage change in diameter versus the thickness of the device (n = 3). 
For thickness of 0.5mm, significantly larger percentage change in diameter was only 
observed when the thickness is doubled and when the difference is between 1mm – 
1.5mm. For thickness between 1mm – 1.2mm, significantly larger percentage change 
in diameter was observed when the thickness difference is ≥ 0.5mm. Beyond a device 
thickness of 1.5mm, there is no significant change in the percentage change in 
diameter. *p<0.05 
3.6.3. Length of Device 
In a study by Yang et al. in a porcine model, it was found that a graft length of 2cm 
within the tibial tunnel would be safe and have sufficient strength for adequate 
rehabilitation following ACL reconstruction surgery. In addition, with a longer graft 
length of 4cm within the tibial tunnel, ultimate tensile strength was found to be greater as 
compared to the group with 2cm length. However, between both groups, there was no 
difference in either graft slippage or total graft movement [131]. Hence, based on the 





3.6.4. Porosity of Device  
Following the previous study in the optimal thickness of the device (see above), where 
the optimal thickness of the device is determined to be 1mm, the porosity of devices of 
thickness 1mm and 0.5mm were compared with the porosity of the tissue augmentation 
silk sleeve device (see Benchmarking with current device).  
 
Briefly, the porosity of the devices (i.e. tissue augmentation silk sleeve device or 3D 
printed devices with thickness 0.5mm and 1mm) were determined using the liquid 
displacement method reported in literature [132-134]. The displacement liquid used was 
ethanol because of its ease of penetration into the pores of the device and being a non-
solvent of Veroclear, TangoBlack or silk, it does not induce shrinkage or swelling of the 
device. The devices were first immersed in a measuring cylinder with a known volume of 
ethanol (V1). After 5 minutes of immersion, the device was then pressed to force air from 
the device and for the penetration of ethanol into the device to fill the pores. This total 
volume of ethanol and ethanol-impregnated device was recorded as V2. After removal of 
the device, the residual volume of ethanol was recorded as V3. Finally the porosity of the 




 ---------------------------- (1) 
The porosity of the silk sleeve tissue augmentation device was found to have a 
significantly higher porosity of 69.84 ± 2.75 % compared with devices of thickness 
0.5mm and 1mm (see Figure 3- 8). In 3D printed parts, there are two types of pores; 
pores by design and pores generated during the process [135]. Since both devices of 
either thickness 0.5mm and 1mm have the same pore design and it is observed that there 




porosity of the Polyjet Veroclear and TangoBlack blend does not contribute to the overall 
porosity of the device with the current printing parameters of strut thickness and density.  
 
Figure 3- 8. Porosity of the tissue augmentation silk sleeve device (see Benchmarking 
with current device) versus 3D printed designs of thickness 0.5mm and 1mm (n = 3). 
The porosity of the silk sleeve tissue augmentation device has a significantly higher 
porosity of 69.84 ± 2.75 % compared with devices of thickness 0.5mm and 1mm.  
 
3.7. Instron Pull-through Test 
The printed devices were then put through a pull-through test with the Instron 3345 
machine. Briefly, a 6.5mm bone tunnel was drilled through 15 pcf cellular foam sawbone 
blocks (Pacific Research Laboratories, Vashon Island, WA, USA). Two porcine flexor 
digitorum profundus tendons were harvested and then sutured together along its length to 
form the tendon graft. The tendon grafts were then loaded onto the device and then pulled 
through the 6.5mm bone tunnel at a speed of 10mm/s with an Instron 3345 machine 
(Instron, Norwood, MA, USA) (see Figure 3- 9)  and the efficacy of the device was 
evaluated from any slippage of the graft from the device during pull through. Videos of 




results showed that with the device, it was much easier to load the tendon graft into the 
device as compared with loading it onto the tissue interface augmentation device. At the 
same time, the pull through strength required for the printed device was also 
approximately half that of the pull through strength required as compared to when the 
tissue augmentation device is used (see Table 3- 6).  
      
Figure 3- 9. Pull through test of porcine graft/sleeve construct (left and middle) and 
tissue augmentation device (left) with Instron machine (n = 3). The graft/sleeve 
construct is pulled at 10mm/s through the bone tunnel of 4cm (left) and is observed 
to remain intact after pull through (middle).  
 
Table 3- 6. Pull through strength (N) of tissue augmentation device and printed 
device (n= 3).   
 
Tissue Augmentation Device Printed Device   
Pull through Strength (N) 0.952 ± 0.001 0.494 ± 0.075 
 
3.8. Design Specifications  
As per the results above, a design freeze was adopted and the design specifications are 
listed below. These specifications were determined to be between the optimal values and 





No. User Needs Specifications Units 
1 Extent of irritation when implanted into the body Moderate Qualitative 
2 Thickness of wall of device 1  mm 
3 Length of device 3  cm 
4 Diameter of device 4.5  mm 
5 Pull through strength 0.9  N 
6 Radial extension of device before failure 10  % 
7 Tensile strength of device before failure  7.5  N 
8 Porosity of device 65 % 
9 Average diameter of pore sizes and its range 200  µm 
10 Degradation rate of device 1.5  Years 
11 Material safe for sterilization methods Yes N.A. 







4. Material Selection Process 
4.1. Silk – Biomaterial for ACL applications 
As previously described in Chapter 1 Section 1.2.3(a)ii, silk is a cheap and biocompatible 
material. In ACL reconstruction surgery, silk is primarily chosen from amongst all the 
synthetic and natural fibres because it is the only protein-based biocompatible fiber which 
matches the mechanical properties of native ACL, is not associated with bioburdens 
commonly present for mammalian-derived materials, maintains its long term mechanical 
tensile integrity in vitro [15] and has a slow in vivo degradation rate [6, 20] which 
allowed for optimal host tissue infiltration and integration [22].  
4.2. Silk as a 3D printable bioink  
As covered in Silk-based bioinks in Chapter 2 and Table 2- 1, there are various pure silk 
or silk-polymer/additive composites that are currently being investigated. A common 
limitation with using silk is the slow gelation process, weak mechanical properties and 
most importantly, the risk of clogging the nozzle head during the printing process. Hence, 
new silk formulations has to be investigated that would be ideal for printing yet at the 
same time, is a biocompatible biomaterial which supports cell growth and proliferation.  
4.3. Rationale for material selection 
Since silk has been ascertained to be an optimal natural fiber for ACL tissue engineering 
applications and its potential for its development to be a silk printable bioink, it may be 
possible that the 3D printed sleeve designs in Chapter 3 could be fabricated with a 
replacement biocompatible silk-based bioink for in vivo implantation. Hence, uniaxial 
tensile testing of the PolyJet materials (see Table 3- 5) and that of silk films were 
conducted with the Instron 3345 machine (Instron, Norwood, MA, USA) to determine if 
the mechanical properties of silk matches up to that of the PolyJet materials. Briefly, with 




published study on mechanical properties of silk films by Lu et al. [136], mechanical 
tensile tests were conducted on both silk films and PolyJet Materials FLX 9070, FLX 
9085 and FLX 9095.  
 
Bombyx Mori silk fibres were degummed, dissolved and dialysed following a modified 
protocol which was adapted from Kaplan [137]. Briefly, unwanted sericin was removed 
via degumming by boiling raw silk fibres in 0.02M Na2CO3 (Sigma Aldrich). Thereafter, 
any residual Na2CO3 (Sigma Aldrich) were removed by washing the silk threads in 
distilled water (dH2O). Degummed silk fibres were then air-dried before being dissolved 
in 9.3M lithium bromide solution (Sigma Aldrich) at 60°C for 4hours to obtain 20% (w/v) 
silk fibroin (SF) solutions. SF solutions were then dialyzed against dH2O for 48hrs with 
at least six changes of dH2O using SnakeSkinTM dialysis tubing (3500 MWCO; Thermo 
Fisher Scientific, Rockford, IL, USA). Dialyzed SF solutions were then centrifuged at 
2000g for 10 minutes to remove impurities, and the supernatant containing the purified 
SF stock solution was collected and kept at 4°C for further processing. The final 
concentration of SF stock aqueous solution was approximately 6% (w/v). To fabricate the 
silk films, 6% SF solution was casted onto 6 well polystyrene plates and left to dry in the 
fumehood. Upon drying, another layer of 6% SF solution was added upon the first layer. 
This process was repeated and lastly, the silk films were methanol treated. Specimens (i.e. 
fabricated silk films and 3D printed PolyJet films) were pre-soaked in distilled water for 
an hour prior to mechanical testing. The specimens were clamped at both ends by the 
pneumatic clamps and then stretched along their longitudinal axis till failure (see Figure 
4- 1).  
 
Results from the mechanical testing (see Table 4- 1) demonstrated that the tensile 




the tensile modulus and ultimate tensile strength of silk was still lower than that of FLX 
9095, which was previously determined in Chapter 3 that it was the optimal PolyJet 
Material for the designed devices to work. Hence, silk/polymer composites were 
considered to improve the mechanical properties of silk to match those of FLX 9095 for a 
translatable biocompatible device.  
Table 4- 1: Mechanical Properties of Silk Films and PolyJet Materials (n = 5) 
Material Silk  FLX9070 FLX9085 FLX9095 
Tensile Modulus 
(MPa)  
18.22 ± 0.97 5.85 ± 0.34 11.57 ± 0.62 29.72 ± 2.16 
Ultimate Tensile 
Strength (MPa) 
2.19 ± 1.05 0.93 ± 0.22 2.03 ± 0.21 3.57 ± 0.61 
Elongation at Break 
(%) 
72.90 ± 80.39 29.05 ± 5.38 36.61 ± 6.11 36.02 ± 7.81 
 
  
Figure 4- 1. Mechanical Testing with Instron Machine. Specimens (i.e. silk films and 




were tested under uniaxial tensile loading along the longitudinal axis (left) till failure 
(right) (n = 5).  
4.3.1. Pure Silk “ink” 
i. High concentration silk  
(a) Material and Methods 
Bombyx Mori silk fibres were degummed, dissolved and dialysed following a modified 
protocol which was adapted from Kaplan [137]. Briefly, unwanted sericin was removed 
via degumming by boiling raw silk fibres in 0.02M Na2CO3 (Sigma Aldrich). Thereafter, 
any residual Na2CO3 (Sigma Aldrich) were removed by washing the silk threads in 
distilled water (dH2O). Degummed silk fibres were then air-dried before being dissolved 
in 9.3M lithium bromide solution (Sigma Aldrich) at 60°C for 4hours to obtain 20% (w/v) 
SF solutions. SF solutions were then dialyzed against dH2O for 48hrs with at least six 
changes of dH2O using SnakeSkinTM dialysis tubing (3500 MWCO; Thermo Fisher 
Scientific, Rockford, IL, USA). Dialyzed SF solutions were then centrifuged at 2000g for 
10 minutes to remove impurities, and the supernatant containing the purified SF stock 
solution was collected and kept at 4°C for further processing. The final concentration of 
SF stock aqueous solution was approximately 5% (w/v). To obtain SF solutions with 
higher concentrations, 10ml of the 5% SF solution was dialyzed against 400ml of 
poly(ethylene)glycol (PEG) solutions (10 000g/mol, Sigma Aldrich) of different 
concentrations for varying durations using Slide-A-LyzerTM dialysis cassettes (3500 
MWCO; Thermo Fisher Scientific, Rockford, IL, USA) at room temperature [138]. The 
concentrated silk solutions of different concentrations were then loaded into syringes and 
preliminarily extruded via various nozzle tips of various sizes (i.e. 18G, 22G, 27G and 














PEG Concentrations (%) 



















2 8.60 2.4 9.40 2.0 10.00 1.8 
3 7.67 8.0 10.67 1.0 11.00 0.7 
4 9.67 1.5 18.20 0.5 33.50 0.2 
 
Table 4- 3: Final SF concentration after dialysis against 20% (w/v) PEG solution 
Duration of Dialysis 
(Hours) 
Final SF Concentration (%) 
(Dialysis against 20% (w/v) PEG) 
Initial SF concentration: 5.6%  Initial SF concentration: 6.4%   
4 16.9 21.2 
5 22.2 28.3 
7 26.0 57.9 










Figure 4- 2. Silk “constructs” formed from concentrated SF solutions. SF solutions 
of 22.2% (w/v) (left) and 26% (w/v) (right) were extruded onto glass slides at 






With the same starting concentration of 5% (w/v) SF solution and initial volume of 10ml, 
it can be seen from Table 4- 2 that with the same duration of dialysis, SF solutions 
dialyzed against higher PEG concentrations yield a higher final concentration of SF. This 
trend was similarly observed for increasing duration of dialysis when the PEG 
concentration was held constant. Concurrently, as the concentration of SF solution 
increased, the final volume of the concentrated SF solution was observed to decrease over 
time. Moreover, when these concentrated SF solutions were loaded into syringes and 
subsequently extruded via the 18G, 22G, 27G and 31G nozzle tips, the only SF 
concentration that yielded a fibre-like filament was 33.50%. However, at 33.50%, the 
volume of the SF solution was too little (i.e. 200µl) for the formation of any visible 
filaments for any post-fabrication treatment. On the other hand, the rest of the SF 
concentrations were observed to have too high a water content for any formation of the 
filamentous shape upon extrusion from the nozzle tip and was observed to spread on the 
glass surface. Rapid evaporation of the SF solution was also observed after extrusion (see 
Figure 4- 2).  
(c) Discussion  
The observed increase in concentration of SF solution was to be expected as the much 
higher salt concentration in the surrounding PEG dialysis solution resulted in the 
movement of water molecules in the SF solution across the membrane of the  dialysis 
cassette into the PEG dialysis solution by osmotic stress [139]. The movement of the 
higher molecular weight PEG molecules across the membrane into the SF solution was 
restricted due to the smaller molecular weight cutoff (MWCO) of the dialysis cassette 
membrane. Hence, with the decrease in the amount of water, the concentration of the SF 
solution increased over time and when higher salt concentrations of dialysis solutions 




solution was the repeatability of this method. While concentrations as high as 33.50% 
were achievable, the volume reduction was 50 times. Attempts to increase the initial 
volume or initial concentration before dialysis induced premature and spontaneous 
gelation within the dialysis cassette (see Table 4- 3) [139]. In addition, high 
concentrations of SF solution had rapid gelation within a span of 48 hours at 4 ̊ C and 
therefore it was not feasible to store the SF solution to have an increased yield. The rapid 
gelation of SF solutions with the increase in SF content had also been similarly confirmed 
in other studies [139, 140].  
 
For silk concentrations below 33.50%, the shear rate of the SF solutions was highly 
dependent on its viscosity and it behaved like a non-Newtonian fluid. This shear thinning 
behaviour indicated the presence of aggregate formation due to hydrophobic/ hydrophilic 
interactions within the SF solution because of silk’s amphiphilic structure [106]. Hence, 
this resulted in non-uniform extrusion and the merging of adjacent structures that were 
extruded. Though 33.50% SF concentration supported the formation and shape retention 
of filament – like fibres, these filaments did not have the adequate mechanical strength 
for further processing. Attempts with methanol treatment resulted in the disintegration of 
the filaments.   
(d) Conclusion  
Hence, it can be concluded that it was neither practical nor feasible to use highly 
concentrated SF solutions as a 3D printable ink. Low SF concentrations did not undergo 
gelation fast enough for shape retention after extrusion while the process of obtaining 
high SF concentrations was not reproducible and had low yields that underwent rapid 




mechanical strength for post-printing processing with methanol to induce a more robust 
construct.    
ii. Temperature sensitive silk  
(a) Material and Methods 
Bombyx Mori silk fibres were degummed, dissolved and dialysed following a modified 
protocol which was adapted from Kaplan [137]. Briefly, unwanted sericin was removed 
via degumming by boiling raw silk fibres in 0.02M Na2CO3 (Sigma Aldrich). Thereafter, 
any residual Na2CO3 (Sigma Aldrich) were removed by washing the silk threads in dH2O. 
Degummed silk fibres were then air-dried before being dissolved in 9.3M lithium 
bromide solution (Sigma Aldrich) at 60°C for 4hours to obtain 20% (w/v) SF solutions. 
SF solutions were then dialyzed against dH2O for 48hrs with at least six changes of dH2O 
using SnakeSkinTM dialysis tubing (3500 MWCO; Thermo Fisher Scientific, Rockford, 
IL, USA). Dialyzed SF solutions were then centrifuged at 2000g for 10 minutes to 
remove impurities, and the supernatant containing the purified SF stock solution was 
collected and kept at 4°C for further processing. The final concentration of SF stock 
aqueous solution was approximately 5% (w/v). To obtain SF solutions with higher 
concentrations, 10ml of the 5% SF solution was dialyzed against 400ml of PEG solutions 
(10 000g/mol, Sigma Aldrich) of different concentrations for varying durations using 
Slide-A-LyzerTM dialysis cassettes (3500 MWCO; Thermo Fisher Scientific, Rockford, IL, 
USA) at room temperature [138]. The concentrated SF solutions of different 
concentrations were then loaded into syringes and preliminarily extruded through 27G 
nozzle tips onto slides pre-cooled at -20 ̊ C at an ambient temperature of -20 ̊ C before 











Figure 4- 3. Extrusion of different concentration of SF solutions onto a pre-cooled 
glass slide at -20̊ C. No uniform fibre formation was observed for 5% (w/v) SF 
concentration (a), 7.5% (w/v) SF concentration (b) and 10% (w/v) SF concentration 
(c).  
 
It can be seen in Figure 4- 3 that with increasing SF concentrations, the finer the fibres 
formed and the faster the freezing and solidification of the SF fibres when extruded under 
temperatures of -20 ̊ C onto pre-cooled slides. Furthermore, when a second layer of SF 
solution was extruded upon the first layer of SF solution, the silk fibres did not fuse but 
instead accumulated to form globules at points along the first layer. Hence, there was no 
uniform fibre formation especially for extrusion of second layer onwards. At the same 
time, the solidified structures thawed rapidly upon removal from the -20 ̊ C environment 
and lost its preliminary solidified structure and shape before any further post-processing 
treatment (i.e. methanol treatment) could be done on the constructs.  
(c) Discussion  
The reason for the formation of the different fibers was due to the differing water content 
in the different concentrations of SF solution. During normal freezing process, the water 
crystals grew at a controllable rate while the silk molecules became less stable, phase 




freezing process was complete [141, 142]. As the extruded SF solution was very small in 
volume (given the volume extrudable through a 27G needle of 0.21mm diameter), the 
freezing process was very rapid. Hence, the extruded silk “filament” was able to hold its 
frozen shape on the glass slide. However, the rate of ice nucleation increased with 
increasing water content [141] (i.e. more dilute silk concentration) and this was observed 
when the filaments from the 5% SF solution tend to have a phase separation between silk 
and water because of the non-uniform freezing rates. This was seen from the globular – 
like structures atop the surface of the denser silk solution on the glass slide surface. The 
difference in water content, with more concentrated SF solutions having lower 
concentration of water, determined the morphology of the filaments being formed. For a 
more lamellar-like filament formation, the ice crystals formed within the SF solution had 
to assume a stable dendritic morphology without any side branches. This could only be 
achieved for SF concentrations more than 6% (w/v) or at temperatures below –80 ̊ C 
[143]. As per observed in Figure 4- 3, as the SF concentration increased from 5% (w/v) 
to 7.5% (w/v) and finally to 10% (w/v), the morphology of the SF filaments changed 
from a globular structure to a more lamellar-like filament. However, upon removal from 
the – 20 ̊ C environment to ambient room temperature, the constructs underwent rapid 
thawing and spread out on the glass slide. This was primarily because the filament 
formation was not stable yet; a freezing duration of 6 – 7 days was usually required for 
the elongation of the folded micelles which aggregated to form stable filaments [144].    
 
Another limitation of this approach was the ink’s inability in building a 3D structure. Due 
to the hydrophobicity of the initial frozen layer and the low temperature at which the 





(d) Conclusion  
As discussed above, it can be preliminarily concluded that this approach was no more 
feasible than the one above. The time that was required for stable filament formation was 
too long and a major concern was its inability to build upwards to form a 3D construct. 
Moreover, the construct was not stable and disintegrated even with minor changes in the 
surrounding temperature. Hence, silk – polymer composites instead of just pure SF 
solutions should be considered as pure SF solutions have weak mechanical properties and 
their compatibility with current 3D printing technologies cannot match up to that of 
commercial 3D printable inks.  
4.3.2. Silk-Polymer Blend “ink” 
i. Silk-PVA  
(a) Material and Methods 
6% (w/v) Poly(vinyl alcohol) (PVA, average mol wt 30,000–70,000, 87–90% 
hydrolyzed) solution was made by dissolving PVA Powder (Sigma Aldrich, St. Louis, 
MO) in dH20 from the Milli-Q system (Millipore, Billerica, MA) and autoclaving the 
mixture at 120 ̊ C for 2hours. Thereafter, 6% (w/v) PVA solution was blended with 6% 
(w/v) SF solution in different ratios (i.e. silk/PVA: 90/10, 80/20 and 70/30) [145] and 
then cast onto 6 well polystyrene cell culture plates. Upon drying, another layer of 
the silk/PVA solution was cast above the first layer and then left to dry. This process 
was repeated a third time before the cast films were methanol treated. Following the 
methanol treatment, the silk/PVA films were first soaked in dH20 before being 
subjected to uniaxial tensile testing with an Instron 3345 machine (Instron, Norwood, 
MA, USA), with a 1000N load cell and at a tensile loading rate of 10mm/minute 
[136]. Samples were mounted and placed in a gold coat sputter (JEOL, Tokyo, Japan) 









Figure 4- 4. Mechanical properties (i.e. tensile modulus (a) and ultimate tensile 
strength (b)) of biomaterials of pure silk films, silk/PVA films (with ratios 90/10 and 
80/20) and PolyJet materials of different stiffness (FLX 9070, 9085 and 9095). 
Significantly higher tensile modulus was observed for pure silk films and PolyJet 
materials FLX9085 and 9095 over silk/PVA films of the ratio 80/20 (**p<0.05), 
PolyJet material FLX 9070 (#p<0.05), PolyJet material FLX 9085 (##p<0.05) and 
PolyJet material FLX9095 (+p<0.05). The tensile modulus and ultimate tensile 
strength of 80% silk/20% PVA films was significantly lower than that of the other 








Figure 4- 5. SEM images of pure silk, silk/PVA films of ratios 90/10 and 80/20 at 
1000x magnification showed increasing porosity (top) and delamination (bottom) 
between the layers as PVA ratio increased.  
 
The tensile modulus of the pure silk films was observed to be significantly higher than 
that of silk/PVA films with PVA content of 20%. However, as compared to the PolyJet 
material FLX9060, the mechanical properties of the pure silk films were still significantly 
weaker. There was no significant difference in mechanical properties when the 
composition of the TangoBlack material decreased (i.e. FLX9050 and FLX9040). 
(c) Discussion  
Silk films become dry and brittle when dried or left in ambient exposure. Hence, in order 
to improve the inferior tensile properties of silk films, synthetic polymers especially PVA 
have been used to mix with silk to form silk/PVA composites with improved mechanical 
properties [146-148]. However, contrary to what was reported in literature, Figure 4- 4 
showed that not only was there no improvement in tensile modulus, there was a 
significant decrease in tensile modulus when the PVA content increased to 20%. This 
could be possibly be due to the macrophase separation of the silk and PVA into a 2 phase 
structure (sea/island) [149] when the silk/PVA composites were cast onto 6 well 
Pure Silk Silk/PVA: 90/10 Silk/PVA: 80/20 
   





polystyrene plates and left to dry. The separation of the two layers was confirmed in 
studies which reported on the spontaneous phase separation of silk and PVA when the 
two solutions were blended and subsequently cast into films [145, 148] and also from the 
SEM images (see Figure 4- 5). As the proportion of PVA increased to 20%, the tensile 
modulus of the silk/PVA: 80/20 films decreased significantly as compared to pure silk 
films. This was to be expected as with the increase in the proportion of PVA within the 
blend, the phase separation would be more distinct with a more irregular microstructure, 
weave structures and spherical particles of non-uniform sizes [149]. There was also 
increased pore density from studies working with freeze dried silk/PVA sponges [147] 
and this was also observed from the SEM images (see Figure 4- 5). Literature also 
reported that due to the immiscibility of silk and PVA resulting in phase segregation of 
the two [146], the surface of the cast silk/PVA films was rough and round-sphere like 
particles suspected to be silk particles were also observed on the surface [148]. This was 
similar to the surface morphology observed under SEM in Figure 4- 5.  
(d) Conclusion  
In conclusion, the current method of mixing PVA with silk did not yield a uniform film 
formation. To form a homogenous formulation of silk and PVA required repeated freeze 
thaw cycles, which resulted in the formation of irreversible silk/PVA gels and not films. 
In addition, the silk/PVA films also had inferior mechanical properties as compared to 
pure SF films. Therefore, PVA is not the ideal synthetic polymer to mix with silk in the 
formulation of a homogenous and stable bioink suitable for 3D printing applications.  
ii. Silk-PEG  
(a) Material and Methods 
Polyethylene glycol (PEG) solution was made by dissolving PEG Powder (8000 MW, 




65% (w/v), 75% (w/v) and 80% (w/v). Thereafter, different concentrations of SF solution 
(i.e. 4% (w/v), 5% (w/v) and 6% (w/v)) were blended with various concentrations of PEG 
in ratios of 1:1 and 2:1 and triplicates of each silk/PEG condition at a volume of 300µl 
were pipetted to a 24-well plate (Corning® Costar®, NY, USA). For monitoring of the 
gelation process and the determination of gelation time, turbidity of the silk/PEG 
composite during gelation was measured spectrophotometrically at the absorbance mode 
(wavelength of 550nm) with defined intervals using a microplate reader (Turner Bio- 
systems, Sunnyvale, CA) at a temperature of 25  ̊C over a period of 5 days (i.e. till no 
change in optical density was observed). SF solutions of concentrations 4% (w/v), 5% 
(w/v) and 6% (w/v) and PEG solutions of concentrations 50% (w/v), 65% (w/v), 75% 
(w/v) and 80% (w/v) were the negative controls for this study. The opacity of the 
silk/PEG gels will increase over time and the change in optical density will quantify the 
turbidity change [150] and hence the gelation time of the silk/PEG gels. For each 
silk/PEG condition, the optical density values were averaged to obtain the change in 
optical density over time. The gelation time was then determined as the time at which the 
optical density reached a value corresponding to half of the maximum optical density 
obtained [150, 151].  At the same time, the silk/PEG composites were loaded into 3ml 
syringe – moulds for the eventual formation of silk/PEG gels and left to undergo 
complete gelation at room temperature. Using an adapted test tube inversion method, the 
determination of gel formation was assessed by the fluidity or the presence of liquid 
accumulation at the bottom of the inverted syringe after 5 days [152]. Thereafter, the 
silk/PEG gels (n = 5) were removed from their moulds and subjected to unconfined 
compression testing with an Instron machine (Instron, Norwood, MA, USA) between 2 
compression platens with a 10N load cell and at a compression loading rate of 
1mm/minute till fracture (Figure 4- 6). After normalizing to sample geometries, the 




stress-strain curve generated and yield strength determined using a 2% strain offset from 
the initial linear region [138, 153].  
         
Figure 4- 6. Mechanical Testing with Instron Machine. Specimens (i.e. silk blend 
gels; circled in red) were sandwiched between compression platens and were tested 
under uniaxial unconfined compression loading along the longitudinal axis (left) till 






Figure 4- 7. Gelation times of silk/PEG composites of ratio 1:1 (represented by bold 
lines) and ratio 2:1 (represented by broken lines). For silk/PEG ratio of 1:1, the 
gelation time decreased as the silk concentration increased from 4% to 6%. 
However, as PEG concentrations increased, the gelation time increased or remained 
approximately constant. No observable trend was observed for silk/PEG composites 
of ratio 2:1 except for 6% silk concentration, where increasing the concentration of 
PEG increased the gelation time.  
 
Comparing across the 3 different silk concentrations (i.e. 4%, 5% and 6%), it can be 
observed (Figure 4- 7) that the gelation time of the silk/PEG composites decreased as 
silk concentration increased. For 4% silk/PEG composites blended in the ratio of 1:1, the 
gelation time remained approximately the same as PEG concentration increased from 50% 
to 80%. On the other hand, there was a slight increase in the gelation time as PEG 
concentration increased from 50% to 80% for the groups with 5% silk/PEG composites 
and 6% silk/PEG composites blended in the ratio of 1:1. Comparing the 2 different ratios 
in which silk was blended with PEG, there was no distinct relationship between the 2 




2:1.  Amongst the silk/PEG composites of 2:1, there was no observable relationship 
between the increase in PEG concentration and gelation time when 5% silk was used for 
the silk/PEG composite. The gelation time for 4% silk/PEG composites remained 
approximately the same as PEG concentration increased from 50% to 75% before 
increasing when the PEG concentration was increased to 80%. The most significant 
relationship between gelation time and concentration of PEG was observed when 6% SF 
solution was used; the shortest gelation time of 11 minutes (Figure 4- 7) was observed 
for 6% silk/50% PEG composites while the gelation time increased sharply with 





Figure 4- 8. Compressive modulus (kPa) of Silk/PEG composites with ratios 1:1 (a) 
and 2:1 (b). For silk/PEG composite ratios of 1:1, significantly higher compressive 
modulus was observed for 6% silk composites with 50% and 65% PEG over 4% 
silk composites with 50% PEG (*p<0.05), 65% PEG (#p<0.05), 75% PEG (^p<0.05) 
and 80% PEG (+p<0.05) and 5% silk composites with 50% PEG (**p<0.05), 65% 
PEG (##p<0.05), 75% PEG (^^p<0.05) and 80% PEG (++p<0.05). However, 6% 
silk composites with 75% and 80% PEG had lower compressive modulus compared 
with 50% PEG (***p<0.05) and 65% PEG (###p<0.05). For silk/PEG composite 
ratios of 2:1, significantly higher compressive modulus was observed for 6% silk 










Figure 4- 9. Yield strength (kPa) of Silk/PEG composites with ratios 1:1 (a) and 2:1 
(b). For silk/PEG ratios of 1:1, significantly higher compressive modulus was 
observed for 6% silk composites with 50%, 65% and 75% PEG over 4% silk 
composites with 50% PEG (*p<0.05), 65% PEG (#p<0.05), 75% PEG (^p<0.05) and 
80% PEG (+p<0.05) and 5% silk composites with 50% PEG (**p<0.05), 65% PEG 
(##p<0.05), 75% PEG (^^p<0.05) and 80% PEG (++p<0.05). However, significantly 
lower compressive modulus was observed for 6% silk/80% PEG composites when 
compared with 50% PEG (***p<0.05) and 65% PEG (###p<0.05). For silk/PEG 
ratios of 2:1, significantly higher compressive modulus was observed for 6% silk 






For silk/PEG composites of ratio 1:1, there was no significant difference in the 
compressive modulus and yield strength as the PEG concentration increased from 50% to 
80% for 4% silk/PEG composites. However, when 5% silk was blended with PEG, there 
was a significant decrease in the compressive modulus and yield strength when PEG 
concentration was increased to 80% when compared with 50%. The compressive 
modulus and yield strength of the blend of 5% silk/50% PEG was observed to be 
significantly higher than that of 4% silk/PEG composites. Comparatively, when the SF 
concentration was increased further to 6%, composites with 50% PEG and 65% PEG 
were found to have significantly higher compressive modulus and yield strength as 
compared to the 4% and 5% silk/PEG composites. Within the 6% silk/PEG composite 
group, 75% PEG was observed to have significantly lower compressive modulus values 
while 80% PEG had significantly lower compressive modulus and yield strength as 
compared to composites with 50% and 65% PEG. Conversely, when the silk/PEG 
composites were blended in the volume ratio of 2:1, there was no significant difference in 
either the compressive modulus or the yield strength across all PEG concentrations when 
the silk concentration was increased from 4% to 5%. When SF concentration was 
increased further to 6% silk, there was a significant increase in the compressive modulus 
and yield strength as compared to the 4% silk/PEG composites with the exception of 6% 
silk/75% PEG blend in terms of yield strength. Particularly, 6% silk/65% PEG blend had 
the most significant increase in compressive modulus and both 6% silk/50% PEG and 6% 
silk/65% PEG had the most significant increase in yield strength when compared with 4% 
and 5% silk composites. There was no observable relationship between compressive 
modulus and the increase in PEG concentration within the 6% silk/PEG composites 
condition. Similarly, this was also observed for yield strength of the silk/PEG composites 
(Figure 4- 9). In general, the mechanical properties of silk/PEG composites with the ratio 




(c) Discussion  
The presence of polar and ionogenic groups in SF enhanced its ability to react with other 
polar and functional groups. When PEG, a strongly hydrophilic polyalcohol, was blended 
with SF solution, the PEG molecules rapidly diffused to the hydrophilic regions of the SF 
molecules and formed abundant hydrogen bonds. This resulted in the breakage of the 
hydration layer around the SF molecules and with the competition for water molecules by 
the PEG molecules, increased the collision of SF and PEG molecules. In addition, with 
the separation of SF molecules into different phases, the folding of the hydrophobic 
regions of the SF molecules was induced. The breaking and reformation of hydrogen 
bonds promoted the SF molecules to intertwine and aggregate with each other. The end 
result was the transition of the random coil structure to the formation of β-sheets within 
the SF molecules, resulting in the gelation of silk/PEG composites [154-156]. As the 
concentration of SF increased, the local density of the silk molecules was higher which 
enhanced the silk/PEG intermolecular interactions and subsequently the silk self-
assembly. Hence, the gelation time was observed to decrease as the concentration of SF 
in silk/PEG composites increased from 4% to 6% for both silk/PEG composites of ratios 
1:1 and 2:1  [154]. At the same time, with increasing silk concentrations, the mechanical 
properties (i.e. compressive modulus and yield strength) increased, with 6% silk/PEG 
having significantly better mechanical properties compared to 4% and 5% silk/PEG 
composites.  
 
Conversely, with concentration of SF held constant and increasing concentrations of PEG, 
the gelation time was observed to increase. This was because with a higher density of 
PEG molecules within the composite, the increase in the viscosity of the blend increased 




counter effects occurring simultaneously; while more SF molecules entrapped in the 
separated phase promoted SF molecules aggregation, the decrease in the collision rate of 
SF and PEG molecules due to increased viscosity [154] led to the decreased rate of 
aggregation of SF molecules. From the results observed from Figure 4- 7, it would seem 
that for silk/PEG composites in a 1:1 ratio, the viscosity of the solution and hence the 
collision rate effect was more prominent, leading to a slight increase in the gelation time 
as PEG concentration increased. This relationship was found to be even more prominent 
for silk/PEG composites of 2:1 ratio where the phase separation effect was even less 
prominent with the increase in the amount of SF molecules; leading to a sharp increase in 
gelation time across increasing PEG concentrations.  
 
Another contributing factor to the slower gelation was also due to the concentration and 
molecular weight of PEG being used. In a similar study with silk/PEG microspheres, it 
was found that for PEG of molecular weights 4000 – 20 000, the addition of PEG to 8% 
(w/v) SF only formed particles [154]. In the current study of blending lower 
concentrations of silk (i.e. 4%, 5% and 6%) with PEG (MW 8000), the gelation that was 
observed could be a mixture of both particles and gel. Within the groups of same SF 
concentration, the increase in PEG concentration enhanced the formation of silk/PEG gel 
microparticles more than gels. Due to the uneven distribution in the highly viscous 
solution, the microparticles may be prevented from forming fiber gel networks due to the 
limited interaction in the increasingly viscous solution hence causing the increase in 
gelation time. The uneven distribution of the microparticles in the resultant silk/PEG 
composite also resulted in the much lower mechanical properties with increasing PEG 
concentrations within a fixed SF concentration group (i.e. 6%). However, the decrease in 
mechanical properties was only significant for PEG concentrations above 65% and above 




the concentrations at which the viscosity was so high that rapid local gelation (i.e. 
aggregation) occurred instead of self-assembly; the lower amount of β-sheet structures 
led to the lower mechanical properties of the resulting silk/PEG micro-particle gel [154].  
(d) Conclusion  
The rationale for choosing silk/PEG composites was because of PEG’s ability in inducing 
rapid silk gelation by easily changing either SF or PEG concentrations or their mixing 
ratios. From the results above, the shortest gelation time achieved with 6% silk/50% PEG 
composites of ratio 2:1 was only 11 minutes. However, this was at the expense of the 
mechanical properties of the composite. Conversely, for silk/PEG composites of better 
mechanical properties (i.e. 6% silk/65% PEG composite of ratio 2:1 with highest 
compressive modulus and yield strength of 18.21 kPa and 3.86 kPa respectively), the 
gelation time was found to be much longer at approximately 39 minutes. Even so, the 
mechanical properties of these silk/PEG gels were still three orders of magnitude lower 
than that of the PolyJet material used in the sleeve design demonstrated above. Hence, 
silk/PEG composites are not an optimal material for the translation of the 3D printable 
device. Neither can it be considered as a 3D printable bio-ink due to its difficulty in 
achieving an optimal silk/PEG ratio that has both high mechanical properties and an 
extremely short gelation time for conventional 3D extrusion printing.  
iii. Silk-SDS 
(a) Material and Methods 
8mM Sodium dodecyl sulfate (SDS) solution was made by dissolving SDS powder 
(Sigma Aldrich) in dH20. Thereafter, 6% (w/v) SF solution was blended with SDS 
solutions at varying ratios and triplicates of each silk/SDS ratio at a volume of 1ml were 
pipetted to a 96-well plate (Corning® Costar®, NY, USA). For monitoring of the 




composites during gelation were measured spectrophotometrically at the absorbance 
mode (wavelength of 550nm) with defined intervals using a microplate reader (Turner 
Bio- systems, Sunnyvale, CA) at a temperature of 25 ̊ C over a period of 2 weeks. 6% 
(w/v) SF solution and 8mM SDS solution were the negative controls for this study. The 
opacity of the silk/SDS gels will increase over time and the change in optical density will 
quantify the turbidity change [150] and hence the gelation time of the silk/SDS gels. For 
each silk/SDS condition, the optical density values were averaged to obtain the change in 
optical density over time. The gelation time was then determined as the time at which the 
optical density reached a value corresponding to half of the maximum optical density 
obtained [150, 151].  At the same time, the silk/SDS composites were loaded into 3ml 
syringe – moulds for the eventual formation of silk/SDS gels and left to undergo 
complete gelation at room temperature. Thereafter, the silk/SDS gels (n = 5) were 
removed from their moulds and subjected to unconfined compression testing with an 
Instron machine (Instron, Norwood, MA, USA) between 2 compression platens with a 
10N load cell and at a compression loading rate of 1mm/minute till fracture (Figure 4- 6). 
After normalizing to sample geometries, the compressive modulus was determined from 
the slope of the initial linear region of the stress-strain curve generated and yield strength 






Figure 4- 10. Gelation times of silk/SDS composites. Gelation time increased as 
proportion of SDS decreased, with maximum gelation time at silk/SDS ratio of 9:1, 
before decreasing as SDS proportions decreased.  
 
From Figure 4- 10, it was observed that when the proportion of SDS was in excess in the 
silk/SDS composites (i.e. silk/SDS ratio of 1:3 and 1:2); the gelation time was extremely 
short with the shortest gelation time of 8 minutes for silk/SDS ratio of 1:3. As the 
proportion of SDS decreased from 75% (i.e. silk/SDS ratio of 1:3) to 7.69% (i.e. silk/SDS 
ratio of 12:1), the gelation time increased from 8 minutes to a maximum of 10.29 days at 
10% SDS (i.e. silk/SDS ratio of 9:1). No observable relationship between silk/SDS ratio 






Figure 4- 11. Compressive modulus (kPa) (a) and yield strength (kPa) (b) of 
silk/SDS composites from ratios 1:3 to 1:1. Silk/SDS composites of ratio 1:1 and 1:2 
had significantly higher compressive modulus and yield strength over composites of 







Figure 4- 12. Compressive modulus (kPa) of silk/SDS composites with ratios 1:1 to 
12:1. Significantly lower compressive modulus was observed for silk/SDS composites 
from 1:1 to 5:1 as compared to their counterparts with ratio 6:1 (*p<0.05), 7:1 




Figure 4- 13. Yield strength (kPa) of silk/SDS composites with ratios 1:1 to 12:1. 
Significantly higher compressive modulus was observed for silk/SDS blend of 1:1 as 
compared to their counterparts with ratio 2:1 (*p<0.05), 3:1 (**p<0.05), 4:1 
(***p<0.05), 5:1 (#p<0.05), 6:1 (##p<0.05), 7:1 (###p<0.05), 8:1 (^p<0.05), 9:1 





As the percentage of SDS decreased from 50% to 7.69% (Figure 4- 12), there was an 
observable increase in compressive modulus with the maximum compressive modulus of 
(139.18 ± 15.40) kPa observed at 9.09% SDS (i.e. silk/SDS ratio of 10:1). In general, for 
odd silk/SDS ratios of 2:1, 4:1, 6:1, 8:1, 10:1 and 12:1, the compressive modulus was 
found to be much higher than that of even silk/SDS ratios of 1:1, 3:1, 5:1, 7:1, 9:1, 11:1. 
Significantly lower compressive modulus was also observed for silk/SDS composites 
with 16.67% - 50% SDS as compared to their counterparts with 7.69% - 14.29% SDS.  
Conversely, as the percentage of SDS decreased from 50% to 7.69% (Figure 4- 13), 
there was a significant drop in yield strength when concentration of SDS dropped from 
50% to 33.3% before increasing again for decreasing concentrations of SDS. The 
maximum yield strength of (8.75 ± 1.61) kPa was observed for silk/SDS composites with 
50% of SDS. Thereafter, with decreasing proportion of SDS, the yield strength gradually 
increased till the next highest yield strength of (3.52 ± 0.78) kPa for silk/SDS blend ratio 
of 10:1.  
(c) Discussion  
The rationale of blending silk with SDS was because even under mild conditions of 37 ̊ C 
body temperature and pH 7, SDS as an anionic surfactant allows for accelerated fibroin 
aggregation and gelation [151]. 8mM SDS concentration was chosen because high 
concentrations of SDS (i.e. beyond 8mM) in the silk/SDS composites were believed to 
hinder gelation.  It had been shown that the anionic groups present in SDS caused 
increased dehydration or salting out of silk fibroin. Due to the electrostatic repulsion, the 
negatively charged sulfonate groups outside of the SF molecules removed the 
surrounding water molecules. Hence, the intermolecular hydrophobic interactions 
between SF molecules and the long alkyl chains of SDS were promoted [157]. This 




The gelation time was also found to be dependent on the dehydration rate by the anionic 
surfactant and hence the concentration of anionic surfactant present [151, 157]; with 
decreasing SDS concentration, the dehydration rate was lower, leading to a longer 
gelation time as observed in Figure 4- 10. Beyond 10% SDS, there was only a slight 
decrease in gelation time attributed to the formation of more hydrophobic micro domains 
within the silk/SDS system because the concentration of SDS had reached its critical 
micellar concentration [151].  
 
Stable gel formation was associated with SDS-induced gelation of silk. The combination 
of hydrophobic and electrostatic forces led to rapid protein folding and particle 
association with the eventual formation of an organised gel network [158] with 
conglomerate silk particles of micro sizes. With the decrease in concentration of SDS and 
hence the increase in concentration of SF solution, the final content of parallel β-sheets 
formed increased [159, 160]. Hence, there was an observed increased in the compressive 
modulus of the silk/SDS gels with the maximum modulus observed for 10% SDS 
concentration. This modulus was comparable to the compressive modulus of silk gels 
fabricated in other studies [139].  
 
However, the positive linear relationship between β-sheet content and yield strength was 
not observed. This could be primarily due to the large slenderness ratio of the gel network 
which favoured the interconnection of clusters with each other. These physical cross-
links were found to produce numerous cracks amongst the clusters [151]. As the 
concentration of SDS decreased, the increase in β-sheets formation increased the stiffness 
in the gels [161]. At the same time, the hydrophobic interactions were more dominant and 
the increase in water molecules led to weakened hydrogen bonds formed between β-




strength as SDS concentration decreased [162]. Conversely, at high SDS concentrations 
(i.e. 50% - 75%), the electrostatic repulsion amongst micellar aggregates became 
increasingly dominant [151]. Hence, as SDS concentration decreased from 75% to 50% 
and the number of negatively charged sulfonate groups and hence repulsion decreased, 
micellar aggregation was increased and promoted the gelation of silk. The increase in β-
sheet content was reflected from the increase in yield strength.  
(d) Conclusion  
Surfactants especially anionic surfactants are known to induce more rapid gelation of silk 
fibroin as compared with silk-polymer composites like silk/PEG with its properties of 
volume exclusion effect and silk/PVA which have to undergo multiple freeze-thaw cycles 
over days for complete gelation [158]. Compared with harsh and nonphysiological 
gelation methods like low pH and high temperature, SDS additives effectively shorten the 
gelation time without harmful effects as long as the concentration of SDS used is below 
the human lethal dose value of 500 – 5000 mg kg–1 body weight [151]. From the results 
above, the shortest gelation time achieved with silk/SDS ratio of 1:3 was only 8 minutes; 
shorter than that for silk/PEG composites. However, the resultant silk/SDS gel has 
extremely weak mechanical properties. Conversely, for silk/SDS composites of higher 
mechanical properties (i.e. silk/SDS blend ratio of 10:1 with highest compressive 
modulus of 139.18 ± 15.40 kPa), the gelation time was found to be extremely long at 
approximately 9.85 days. The inverse relationship between gelation time and mechanical 
properties for silk/SDS composites does not make it an ideal bioink material. Therefore, 
another material capable of rapid gelation or the induction of rapid silk gelation has to be 




iv. Silk-SDS Pluronic  
(a) Material and Methods 
30% (w/v) Pluronic solution (i.e. Poloxamer 407, Sigma Aldrich) was blended with the 
silk/SDS composite solutions (as above) at a ratio of 1:1. Thereafter, the 
silk/SDS/Pluronic composites were then left at room temperature for a period of 2 weeks 
for complete gelation before the composites were put to the extrusion test. Briefly, the 
composites were loaded into 3ml syringes before being extruded through a 22G tapered 
nozzle tip onto glass slides to form a rectangular construct. Thereafter, adopting a layer 
by layer technique, more layers are extruded atop the previous layer to form a 3D 
construct. For a preliminary examination of which silk/SDS/Pluronic composite ratios 
had the potential to be a bioink, the following parameters were examined for the extruded 
constructs over a period of 2 weeks: 
During Extrusion Post Extrusion  
 Shear thinning  
 Thixotropy  
 Mechanical & Structural Integrity  
 Mechanical & Structural Integrity  
 Rapid gelation   
 
Using open source imaging software FIJI (2015), the dimensions of the extruded 
constructs were measured and the percentage shrinkage in height of the constructs were 
also calculated and plotted as shown in Figure 4- 16.  
(b) Results 
In order to conduct a preliminary assessment of the silk/SDS/Pluronic composites that 
would best fit the parameters above, the extruded constructs were assessed based on the 
observations observed during and after extrusion and tabulated in Table 4- 4. Briefly, the 
parameters of shear-thinning and thixotropy (i.e. time-dependent shear-thinning) of the 
bioink material were assessed from possible nozzle clogging within the nozzle tip and the 




based upon the shape fidelity of construct formed and if the construct collapsed under the 
weight of the new extruded layers above and its stability at room temperature and 
conditions.  
 
In general, the silk/SDS/Pluronic composites were observed to undergo complete gelation 
and had reached a stable state after a period of 21 days. With the Pluronic concentration 
held constant for all silk/SDS/Pluronic composites, as the concentration of SF solution 
increased, the ability of the bioink to form filamentous structures increased with no 
nozzle clogging observed. The extrusion was also smoother and the length of the 
extrudable fibres increased as compared with silk/SDS/Pluronic composites with lower 
concentration of silk which broke easily (Table 4- 4). The shape fidelity also increased 
with more stable 3D structures being formed; there was no visible collapse of the 
structure under the newly added layers and no visible spreading of the bioink material on 
the surface onto which the bioink material was extruded upon (Figure 4- 15). The 
constructs were observed to have good fusion between the layers and were increasingly 
stable at room temperature and pressure (Table 4- 4). When the constructs were left to 
dry for 24 hours at room temperature and pressure, there was 50% to 60% shrinkage in 
height across all groups with no significant difference between the groups (Figure 4- 16).  
 
Figure 4- 14. Extruded constructs of silk/SDS/Pluronic composites of silk/SDS ratios 
of 2:1 to 10:1. The extruded constructs were observed to shrink in height 24 hours 





Figure 4- 15. Extruded constructs of silk/SDS/Pluronic composites of silk/SDS ratios 
of 2:1 to 10:1 over a period of 3 weeks. The shape fidelity, structural and mechanical 
integrity of the constructs improved with increasing silk concentration and 
increasing duration.   
 
 
Figure 4- 16. Percentage Shrinkage in height of extruded constructs when left to dry 
for 24 hours at room temperature and pressure. Across all groups, the constructs 




Table 4- 4: Observable parameters of extruded constructs with silk/SDS/Pluronic composites of different silk/SDS ratios 
during and post extrusion. Y indicates yes while N indicates no.  
Parameters 
Silk/SDS Ratios (Silk/SDS composites are blended with Pluronic in a 1:1 ratio) 
2:1 3:1 4:1 5:1 6:1 7:1 8:1 9:1 10:1 
During Extrusion 
1.Nozzle Clogging N N N N N N N N N 
2.Smooth Extrusion  N N N Y Y Y Y Y Y 
3.Formation of filament  N N Y Y Y Y Y Y Y 
Post Extrusion 
1.Shape Fidelity N N N Y Y Y Y Y Y 
2.Construct collapse  Y Y N N N N N N N 
3.Fusion between layers Y Y Y Y Y Y Y Y Y 






(c) Discussion  
Pluronic, also known as poloxamer 407, is a high molecular weight non-ionic 
surfactant. Due to the presence of hydrophobic interactions of its poly(propylene 
oxide) groups, it was able to undergo reversible gelation with a change in 
temperature. Hence, it has been often used as a sacrificial material in 3D bioprinting 
[163]. Conversely, due to the strong intermolecular hydrogen bonds present in SF, 
gelation of SF is irreversible [164]. When silk was blended with Pluronic, Pluronic 
caused a dehydrating effect when the hydrophilic groups of Pluronic removed the 
water molecules from the SF molecular chains and formed hydrophobic interactions 
with the chains because of its tendency for polymer binding, [157, 165]. Due to the 
enhanced hydrophobic interactions and hydrogen bonds between SF and Pluronic, 
not only was silk gelation accelerated, the reversal of gelation was also facilitated. It 
was suspected that Pluronic micelles formed did not influence silk fibroin gelation 
but instead, enhanced its own gelation [164]. With the addition of another ionic 
surfactant, SDS, to the silk/Pluronic blend, the critical micellar temperature of 
Pluronic was affected. In normal circumstances, at low temperatures, Pluronic is 
completely soluble in water and is thus liquid with its preference for polar 
conformation. As temperature increased, Pluronic-Pluronic interactions increased 
while Pluronic-water interaction decreased. This resulted in Pluronic forming a gel at 
room temperature. In the silk/SDS/Pluronic composite, SDS bound to Pluronic and 
suppressed this micellar formation. As SDS concentration increased, the amount of 
free Pluronic molecules decreased; hindering the aggregation of Pluronic molecules 
and the formation of micelles [165, 166]. Hence, there was no shape fidelity of the 
filaments formed and the bioink tend to spread on the printing substrate (Figure 4- 




silk/SDS/Pluronic composites of high SDS concentrations (i.e. ratios of 2:1, 3:1). The 
gelation temperature of Pluronic was also increased such that the composites 
assumed a sol-gel form instead of the normal gel for Pluronic at room temperature. 
Nonetheless, with the shear thinning behaviour of both silk solution and Pluronic, no 
nozzle clogging was observed during extrusion.  
 
 After a period of 21 days, it was believed that with both SDS and Pluronic present as 
surfactants, the gelation of silk was accelerated which allowed for the formation of a 
soft gel which was extrudable yet able to maintain shape fidelity upon extrusion. The 
brittleness of normal silk gels was also found to be absent and this could be due to the 
presence of the surfactants which affected the gelation and hence the mechanical 
properties of the silk/SDS/Pluronic gel. Upon drying at room temperature, the 
composites were observed to undergo dehydration and this was evident from the 50% 
- 60% shrinkage in the constructs. This was an important feature to consider as the 
water swelling features of these composites will affect both the mechanical strength 
and the resolution of the eventual construct.   
(d) Conclusion  
It can be concluded that the silk/SDS/Pluronic blend was able to form extrudable 
hydrogel of different extrudability and mechanical properties and may be a promising 
future bioink material. By changing the proportion of silk, SDS and Pluronic, the 
mechanical properties, viscosity and shear thinning properties can be optimised to have 
both mechanical strength and printability at the same time. The rationale behind this 
present study of simple observation and assessment of the workability of the 
silk/SDS/Pluronic composites was to conduct a preliminary selection and elimination of 




such as viscosity, shear thinning properties, adhesion and surface tension properties is 
required, this study provided the basis for future investigation of parameters like Pluronic, 
silk and SDS concentrations, the ratios for the three solutions to be blended and how each 
parameter is related to each other for the development of a novel and ideal bioink suitable 






















5. Comparative Evaluation of Bioink materials 
As discussed in Section 2.3.3 Properties of a bio-ink, there are many properties that a 
material has to have for it to be an ideal bioink. Five different materials were investigated 
in the present study and were compared and evaluated based on these performance 
metrics namely biocompatibility, compatibility with extrusion printing, biomimicry, 
resolution, scalability, practicality, mechanical and structural integrity, bioprinting and 
post-bioprinting processing time and degradability [102] in Table 5- 1and Table 5- 2.  
 
At present, current 3D printing technologies are based on subsequent gelation post 
extrusion of the polymer solution. This fabrication technique is based on a layer-by-layer 
approach and in order for a solution to be self-supporting, it has to have high viscosity or 
able to gel rapidly on the printing surface [167].  
 
Pure silk solution was initially considered as a bioink material because of its widespread 
use in ACL reconstruction applications and the ability to process SF solution into 
numerous material formats [137]. Low concentrations of silk solution have been known 
to have extremely slow rates of gelation under physiological conditions [151, 157, 168, 
169]. This poses a challenge to the maintenance of the shape fidelity and resolution of the 
final construct post extrusion. In contrast, high concentrations of silk are highly viscous 
which help in the maintenance of the shape fidelity post extrusion. However, highly 
viscous SF solutions often have the problem of nozzle clogging during extrusion and a 
gelation rate too rapid for long term storage. Moreover, the results above have proved 
that the process of fabricating highly concentrated silk solution was non-reproducible due 
to the randomness and irreversibility of SF gelation and the yield was also extremely low. 




extrusion treatment. Further studies investigating the temperature responsiveness of silk 
solutions also proved that freezing provided an alternative but temporary “gelation” 
technique and thus maintenance of shape fidelity of the extruded filaments. Nonetheless, 
when the temperature was raised to room temperature, the extruded SF filaments rapidly 
thawed and were found to coalesce with adjacent filaments. For the formation of stable 
silk filaments, the time consuming process of repeated freeze-thaw cycles were required. 
Hence, these factors do not make pure silk solutions an ideal bioink material for 3D 
extrusion applications. 
 
Hydrogels are commonly used in 3D printing applications because they minimize the 
collapse of the printed constructs by preserving their structures [167, 170-172]. Though 
silk hydrogels have the potential to be developed as a potential bioink material, they are 
too brittle for further applications [173, 174] and their gelation process is also random, 
non-reproducible and non-uniform. Therefore, other methods of silk gelation have to be 
considered; namely having silk-composite hydrogels like silk-PVA hydrogels or simply 
having precipitating agents like large polymeric precipitating agent PEG, surface agents 
like SDS surfactant and low molecular weight neutral additives like Pluronic [158]. There 
are two general conditions required for the 3D printing of high-fidelity constructs. Firstly, 
the extruded droplets must maintain their raised 3D profile instead of spreading 
completely flat. Secondly, extruded droplets has to gel sufficiently to prevent the coalesce 
of new extruded droplets adjacent or atop them [175].  
 
In the first approach of silk-composite hydrogels, PVA was the chosen synthetic polymer 
as it had been found to be effective in the improvement of physical properties of SF [176]. 
It had been widely reported in literature that through repeated freeze thaw cycles, 




found that silk and PVA were immiscible and undergo macrophase separation when the 
silk/PVA composite films were cast and left to dry at room temperature. This resulted in 
the eventual delamination of the layers of the silk/PVA composite films which 
contributed to the inferior mechanical properties as compared to pure SF films. For 
homogenous silk/PVA composites, numerous time consuming freeze thaw cycles are 
required. Hence, silk/PVA composites did not fulfil the parameter of fast gelation for an 
ideal bioink.  
 
An alternative polymer, PEG, was used as it can rapidly crosslink and induce the rapid 
gelation of SF [152, 178]. However, in the present study, when PEG was added in an 
equal proportion with SF, there was no reduction in gelation times observed. Gelation 
times even increased with increasing PEG concentration when half the proportion of PEG 
was added to SF. Composites of 6% silk/50% PEG of 2:1 ratio underwent rapid gelation 
but had extremely weak mechanical properties and thus structural integrity post extrusion. 
Though increasing the silk concentrations were found to have improved mechanical 
properties and faster gelation times, the final silk/PEG constructs did not have the 
mechanical strength for further post-extrusion processing. In addition, the constructs 
disintegrated upon contact with water due to the high solubility of PEG in water. Last but 
not least, blending other polymers (either PVA or PEG) to silk also affected the 
biocompatibility and biodegradability of silk fibroin [179].  
 
Surface agents like SDS surfactants were then considered for the rapid gelation of SF. In 
the present study, SDS was shown to be an effective gelling agent with a significant 
reduction in gelation time to mere minutes when high concentrations of SDS was used. 
However, the higher the content of SDS present in the silk/SDS composite, the weaker 




their structural integrity and the extrusion resolution was very poor. In addition, high 
concentrations of SDS (i.e. more than 1% SDS) are above the tolerance levels for human 
use and are thus toxic for tissue engineering applications [178]. Conversely, silk/SDS 
composites with low SDS content formed stable but irreversible, rubber-like gels at room 
temperature, had good mechanical properties but were non-extrudable through the nozzle. 
Therefore, in order to improve on the extrudability of the silk/SDS gels, an alternative 
material capable of rapid gelation had to be considered.   
  
Pluronic, commonly used as a hydrogel or a sacrificial bioink for 3D printing applications, 
was studied for its interaction with silk/SDS gels. Due to its non-biodegradability in the 
human body, it has limited use for tissue engineering applications [180, 181]. However, 
Pluronic can be easily removed; thus, it was added to silk/SDS gels as a sacrificial 
material for the rapid gelation and the maintenance of shape fidelity of constructs post 
extrusion. This composite material was stable at room temperatures; it did not degrade 
over time and its extrudability remained even after 3 weeks at room temperature. Upon 
complete gelation of the silk/SDS/Pluronic constructs, Pluronic can then be leached out 
from the printed constructs and stable bioink materials were formed. One major concern 
with the addition of Pluronic was the significant decrease in the mechanical strength of 
the silk/SDS/Pluronic composites. Though the composites were now extrudable and were 
able to build up to form 3D structures, the mechanical and structural integrity of the 
constructs were limited. When the silk/SDS/Pluronic composites were removed from 
their moulds, its original form and structure was lost immediately and the composite 
material exhibited spreading on the printing surface. The extruded constructs were also 
observed to have 50% - 60% shrinkage in height when left to dry at room temperature. 
This shrinkage was significant as the water content of the extruded constructs may affect 




In conclusion, of all the silk and silk-composite materials investigated thus far, 
silk/SDS/Pluronic composite material showed the most potential of being a future 
biocompatible bioink due to its extrudability, mechanical and structural integrity at room 






Table 5- 1: Comparison of silk and silk-based composites as potential bio-inks  
 
Parameters 
Silk and Silk-based Composites  
Concentrated SF Temperature – sensitive SF Silk/PVA Silk/PEG Silk/SDS Silk/SDS/Pluronic 
1 Biocompatibility       
2 Compatibility with extrusion printing       
3 Biomimicry       
4 Resolution       
5 Scalability       
6 Mechanical and Structural Integrity       
7 Short Processing Time       
8  Degradability       
9 Practicality        
 
Table 5- 2: Comparison of quantitative parameters of silk and silk-based composites as potential bio-inks 





Silk/PVA Silk/PEG Silk/SDS Silk/SDS/Pluronic 
1 Tensile Modulus (MPa) N.A.* N.A.* 16.9 ± 1.5 N.A.* N.A.* N.A.* 
2 Ultimate Tensile Strength (MPa) N.A.* N.A.* 2.5 ± 1.4 N.A.* N.A.* N.A.* 
3 Compression Modulus (kPa) N.A.*  N.A.*   N.A.* 14.9 ± 4.3 2.0 ± 0.5 N.A.** 
4 Yield Strength (kPa)  N.A.*  N.A.*  N.A.* 3.7 ± 0.8 0.5 ± 0.3 N.A.** 
5 Gelation Time (Hours)  24 Months N.A.*** 0.183 0.134 Instantaneous 
*No experimental results were obtained as these composites are not able to achieve a stable form for mechanical testing with the Instron machine.  
**No experimental results were obtained as these composites were not stable for transfer between platforms for mechanical testing with the 
Instron machine.  




6. Conclusion and Recommendation for future work 
6.1. Conclusion  
ACL tears have a high rate of incidence amongst athletes. However, the native ACL has 
poor healing ability due to insufficient vascularization and this eventually leads to 
degenerative joint diseases. The current clinical treatment of surgical ACL reconstruction 
with biological grafts primarily focuses on mechanical fixation instead of the histological 
osteointegration of the graft within the bone tunnel. Hence, the aim of the present thesis 
was to design and develop a 3D printed device that will have its future application in 
ACL reconstruction surgery; a graft sleeve which helps in the promotion of 
osteointegration at the bone-tendon-graft interface within the bone tunnel.  
 
Based on user needs of the graft sleeve and benchmarking it against a similar device, the 
tissue interface augmentation device for ligament or tendon reconstruction, various 
scaffold designs were explored and developed using Solidworks and subsequently printed 
with a 3D printer. The feasibility and efficacy of the designs were evaluated and 
improvements were made, with the final design being a hollow and porous cylinder with 
teethed protrusions regularly spaced along the interior wall of the scaffold. This design 
was found to have the grip strength to “bite” onto the tendon graft to ensure smooth pull-
through of the graft – sleeve construct through a sawbone bone tunnel model without 
slippage of the graft out of the graft – sleeve construct.  
 
In order to determine if the current design does indeed promote osteointegration at the 
graft and bone tunnel interface of in vivo ACL reconstruction, the graft sleeve has to be 
fabricated with a biocompatible material. Hence, concurrently, various silk-based 




for its subsequent application as a biomaterial for printing of the graft sleeve. Initial 
studies with pure silk solutions showed that even though braided silk fibres were a 
comparable replacement for native ACL, as a potential bioink, its gelation time was too 
slow for mechanically and structurally stable constructs to be formed. Further studies 
with silk/polymer composites, namely silk/PVA and silk/PEG, similarly showed slow 
gelation times. While faster gelation times may be achieved with increased 
concentrations of these gelling agents, very often these composite materials have inferior 
mechanical properties. SDS surfactants were an alternative additive that was added to silk 
to induce rapid gelation. Silk/SDS gels with low surfactant content were found to be very 
stable and had superior mechanical properties though gelation time was extremely long. 
On the other hand, fast gelling silk/SDS constructs had the same limitation of having 
inferior mechanical properties as the silk-polymer gels. Hence, Pluronic as an alternative 
gelling agent and sacrificial material was added. It was found that this silk/SDS/Pluronic 
composite material had the extrudability and the mechanical strength required for the 
extrusion of stable 3D constructs. Thus, it is highly possible that this novel composite 
material can be further developed and optimised for its final application as a printable and 
biocompatible 3D printing bioink.  
 
The studies in this thesis were divided into 2 main phases, the design and the material 
phase, with the objectives under each phase achieved and answered. Therefore, the 
overarching aim of this thesis, which was to design and develop a 3D printed graft sleeve 
for its future application in ACL reconstruction surgery to enhance osteointegration at the 




6.2. Recommendations for future work 
6.2.1. Recommendations for Design of Device  
Further testing of the silk sleeve device on in vitro porcine bone models is required for a 
more accurate evaluation of the efficacy of the design as there are mechanical and 
morphological differences between sawbones models and porcine bone models. This can 
be done by drilling a bone tunnel through the porcine bone models similar to that of 
clinical ACL reconstruction surgeries and then pulling the silk sleeve-tendon graft 
construct through this tunnel. Through this study, the actual mechanical strength of the 
device and its grip strength on the tendon can be quantified and evaluated for its efficacy 
during the initial graft pull-through for ACL reconstruction surgeries. Thereafter, we 
expect more improvements to be made to the design of the device to address its current 
limitations.  
6.2.2. Recommendations for Material of Device  
Since this was a preliminary study to narrow down potential silk-composite materials 
ideal for bioprinting of the silk sleeve scaffold for ACL reconstruction surgeries, further 
characterisation and optimisation studies on the rheological, physical and chemical 
properties of the biomaterial and the blending ratios are required. It can be hypothesized 
that with a reduction in the concentration of Pluronic, the mechanical and structural 
integrity of the composite material will improve yet this may affect the subsequent 
extrudability of the material. Hence, a balance between Pluronic, silk and SDS 
concentrations and compositions of the composite material should be achieved in order to 
have a mechanically stable and extrudable bioink.  
 
Further testing of the material should also be conducted with the printing of the bioink 




printing technologies. The extrudability of the bioink material and the mechanical and 
structural integrity of the eventual construct are also highly dependent on the parameters 
of printing (i.e. splicing profile, strut density, strut thickness, distance between the layers 
in the z – direction). Hence, not only should the material compositions be optimised, the 
printing parameters of the 3D printing modality should also be studied and optimised. At 
the same time, the mechanical properties of the silk/SDS/Pluronic composite material and 
the final biomaterial should also be determined with the RSA3 Dynamic Mechanical 
Analyzer (TA Instruments, New Castle, DE) [123] and compared with the mechanical 
properties of conventional Rapid Prototyping material FLX9095 to ensure translatability 
of results.  
 
In general, the results from the studies investigating the material of the device provided a 
stepping stone for the development of future silk-based bioinks compatible with 
commerical 3D printing technologies. At the same time, results from the design aspect of 
this thesis provided a cornerstone for the development of efficacious designs for future 
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